image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
ab6a760a42658bc9ce805a146a2949577ca54d19d52b33f988209f7235402ea5.png | simple | <table><tr><td> </td><td>AS</td><td>FA</td><td>SS</td><td>AC</td><td>EF</td><td>WO</td><td>CLDQ</td></tr><tr><td>PF</td><td>0.597</td><td>0.762</td><td>0.691</td><td>0.744</td><td>0.636</td><td>0.438</td><td>0.756</td></tr><tr><td>RP</td><td>0.643</td><td>0.717</td><td>0.646</td><td>0.667</td><td>0.614</td><td>0.480</t... | <table><tr><td></td><td>AS</td><td>FA</td><td>SS</td><td>AC</td><td>EF</td><td>WO</td><td>CLDQ</td></tr><tr><td>PF</td><td>0.</td><td>0.76</td><td>0.691</td><td>0.</td><td>0</td><td>0.43</td><td></td></tr></table> | <table><tr><td></td><td>AS</td><td>FA</td><td>SS</td><td>AC</td><td>EF</td><td>WO</td><td>CLDQ</td></tr><tr><td></td><td>597</td><td>2</td><td></td><td>744</td><td>.636</td><td>8</td><td>0.756</td></tr><tr><td>RP</td><td>0.643</td><td>0.717</td><td>0.646</td><td>0.667</td><td>0.614</td><td>0.480</td><td>0.735</td></tr>... |
e846d7b711f36c6af1b5e1ab78a71b8d488b1d0e84d4a0a0c018c3e5cb57acda.png | simple | <table><tr><td>CNVs</td><td>Copy numbers</td><td>Related genes</td><td>Related pathways</td></tr><tr><td>rs2002594; rs1986617</td><td>1</td><td>FAM162A</td><td>Mitochondrial apoptotic cascades</td></tr><tr><td>rs10517547; rs10517548; rs2122642; rs2345041; rs1823535; rs1823536; rs1470724</td><td>1</td><td>LPHN3</td><td>... | <table><tr><td>CNVs</td><td>Copy numbers</td><td>Related genes</td><td>Related pathways</td></tr><tr><td>rs2002594; rs1986617</td><td>1</td><td>FAM162A</td><td>Mitochondrial apoptotic cascades</td></tr><tr><td>rs10517547; rs10517548; rs2122642; rs2345041; rs1823535; rs1823536; rs1470724</td><td>1</td><td>LPHN3</td><td>... | <table><tr><td>CNVs</td><td>Copy numbers</td><td>Related genes</td><td>Related pathways</td></tr><tr><td></td><td></td><td>M1</td><td>; metabolism of carbohydrates</td></tr><tr><td>rs137964; rs10483201</td><td>1</td><td>GRAP2</td><td>T cell receptor signaling pathway</td></tr><tr><td>rs10491333</td><td>4</td><td>HLA-DQ... |
2511a5f77900e871a37c5f222e7dda045f555585bebd743a3f925bf7518fd09e.png | simple | <table><tr><td>Gene symbol</td><td>Description</td><td>Position (Mb)</td><td>MiRNA</td><td>Packages</td></tr><tr><td><i>RNF111</i></td><td>Ring Finger Protein 111</td><td>6.32–6.36</td><td>miR-142-3p</td><td>Targetscan</td></tr><tr><td><i>TCF12</i></td><td>transcription factor 12</td><td>6.90–7.00</td><td>m... | <table><tr><td>Gene symbol</td><td>Description</td><td>Position (Mb)</td><td>MiRNA</td><td>Packages</td></tr><tr><td>RNF111</td><td>Ring Finger Protein 111</td><td>6.32–6.36</td><td>miR-142-3p</td><td>Targetscan</td></tr><tr><td>TCF12</td><td>transcription factor 12</td><td>6.90–7.00</td><td>miR-142-5p</td><td>MIRDB, T... | <table><tr><td>Gene symbol</td><td>Description</td><td>Position (Mb)</td><td>MiRNA</td><td>Packages</td></tr><tr><td>MAPK6</td><td>Mitogen–Activated Protein Kinase 6</td><td>8.42– 8.45</td><td>miR-142-5p</td><td>Targentscan</td></tr></table> |
8033eba3598a07097a50c8fe38db2ac03eb56f5eaf90debf3adebf00784bb9bc.png | complex | <table><tr><td rowspan="2">Compounds</td><td colspan="2">Bradykinin <sup>a</sup></td><td colspan="2">Renin substrate tetra-decapeptide <sup>a</sup></td></tr><tr><td>S/N</td><td>Sig. Int.</td><td>S/N</td><td>Sig. Int.</td></tr><tr><td>1</td><td>711</td><td>56530</td><td>551</td><td>47162</td></tr><tr><td>2</td><td>540</... | <table><tr><td rowspan="2">Compounds</td><td colspan="2">Bradykinin a</td><td colspan="2">Renin substrate tetra-decapeptide a</td></tr><tr><td>S/N</td><td>Sig. Int.</td><td>S/N</td><td>Sig. Int.</td></tr><tr><td>1</td><td>711</td><td>56530</td><td>551</td><td>47162</td></tr><tr><td>2</td><td>540</td><td>23276</td><td>4... | <table><tr><td>18</td><td>332</td><td>101983</td><td>299</td><td>61957</td></tr><tr><td>19</td><td>294</td><td>55402</td><td>200</td><td>13615</td></tr><tr><td>20</td><td>286</td><td>13022</td><td>514</td><td>14110</td></tr><tr><td>21</td><td>244</td><td>53297</td><td>446</td><td>36294</td></tr><tr><td>22</td><td>427</... |
58f398f6ee0a00bf8770fb1efbfd95ec1accfce37df7c0356e622d638f21f22b.png | simple | <table><tr><td>Variable</td><td>Number</td><td>Percentage</td></tr><tr><td>Intravenous drug users</td><td>20</td><td>5.8</td></tr><tr><td>Surgery</td><td>144</td><td>41.6</td></tr><tr><td>Blood transfusion</td><td>40</td><td>11.6</td></tr><tr><td>Transplantation</td><td>1</td><td>0.3</td></tr><tr><td>History of hepatit... | <table><tr><td>Variable</td><td>Number</td><td>Percentage</td></tr><tr><td>Intravenous drug users</td><td>20</td><td>5.8</td></tr></table> | <table><tr><td>Variable</td><td>Number</td><td>Percentage</td></tr><tr><td>Surgery</td><td>144</td><td>41.6</td></tr><tr><td>Blood transfusion</td><td>40</td><td>11.6</td></tr><tr><td>Transplantation</td><td>1</td><td>0.3</td></tr><tr><td>History of hepatitis in the family</td><td>186</td><td>53.8</td></tr><tr><td>Uter... |
a98ce093ae9dcefec13920c93c5d6837db621bf6b4b34e3c4d522b9192b7d870.png | complex | <table><tr><td>Variables</td><td colspan="2">Univariate analysis</td><td></td><td colspan="2">Model 1</td><td></td><td colspan="2">Model 2</td></tr><tr><td></td><td>HR (95%CI)</td><td><i>p</i> value</td><td></td><td>HR (95%CI)</td><td><i>p</i> value</td><td></td><td>HR (95%CI)</td><td><i>p</i> value</td></tr><tr><td>Ag... | <table><tr><td>Variables</td></tr><tr><td></td></tr><tr><td>Age (years)</td></tr><tr><td>Sex (1 = male, 2 = female)</td></tr><tr><td>TC (mmol/L)</td></tr><tr><td>Elevated WC</td></tr><tr><td>Elevated TG</td></tr><tr><td>Elevated BP</td></tr><tr><td>Reduced HDL-C</td></tr><tr><td>Smoking</td></tr><tr><td>HTGW</td></tr><... | <table><tr><td colspan="2">Univariate analysis</td><td></td><td colspan="2">Model 1</td><td></td><td colspan="2">Model 2</td></tr><tr><td>HR (95%CI)</td><td>p value</td><td></td><td>HR (95%CI)</td><td>p value</td><td></td><td>HR (95%CI)</td><td>p value</td></tr><tr><td>1.1 (1.0-1.1)</td><td>0.011</td><td></td><td>1.0 (... |
43efdb13f7b7070e4a3c8feba82a46f30cb8e4e1809a457c781ab48eaeda9aad.png | complex | <table><tr><td> </td><td colspan="2">Perprotocol</td><td colspan="2">Intention to treat</td></tr><tr><td> </td><td>Odds ratio (95% CI)</td><td><i>P</i> value</td><td>Odds ratio (95% CI)</td><td><i>P</i> value</td></tr><tr><td>Age</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> <60 years old</td><td>1.0 (re... | <table><tr><td></td><td colspan="2">Perprotocol</td><td colspan="2">Intention to treat</td></tr><tr><td></td><td>Odds ratio (95%</td><td>P val</td><td></td><td>P va</td></tr></table> | <table><tr><td></td><td> CI)</td><td>ue</td><td>Odds ratio (95% CI)</td><td>lue</td></tr><tr><td>Age</td><td></td><td></td><td></td><td></td></tr><tr><td><60 years old</td><td>1.0 (referent)</td><td></td><td>1.0 (referent)</td><td></td></tr><tr><td>≥60 years old</td><td>1.33 (0.61–2.92)</td><td>0.478</td><td>1.16 (0.55... |
0d2884efc9475302b77f01b300ca00e895bb66acc643cb9e65039548023e7ca4.png | simple | <table><tr><td> </td><td>σ (MPa)</td><td><i>STD</i></td><td><sub><i>λ</i></sub></td><td><i>STD</i></td></tr><tr><td>SV- Longitudinal</td><td>5.38</td><td>0.6</td><td>1.32</td><td>0.04</td></tr><tr><td>SV- Circumferential</td><td>2.61</td><td>0.67</td><td>1.55</td><td>0.06</td></tr><tr><td>UV- Longitudinal</td... | <table><tr><td></td><td>σ (MPa)</td><td>STD</td><td>λ</td><td>STD</td></tr></table> | <table><tr><td>SV- Longitudinal</td><td>5.38</td><td>0.6</td><td>1.32</td><td>0.04</td></tr><tr><td>SV- Circumferential</td><td>2.61</td><td>0.67</td><td>1.55</td><td>0.06</td></tr><tr><td>UV- Longitudinal</td><td>1.65</td><td>0.11</td><td>1.33</td><td>0.04</td></tr><tr><td>UV- Circumferential</td><td>0.97</td><td>0.19... |
0dfdd110ff0283a2db9a0e580b711d5df8a59223f4340ee75107809e2cd8c107.png | complex | <table><tr><td>Platform</td><td colspan="6">System</td><td colspan="7">Applications</td></tr><tr><td></td><td>IMU</td><td>GPS</td><td>LIDAR</td><td>Camera</td><td>DG payload weights</td><td>Cost</td><td>Large area</td><td>Small area</td><td>Mobility</td><td>Weather limitation</td><td>DG accuracy (3DRMS)</td><td>Cyber c... | <table><tr><td>Platform</td><td colspan="6">System</td><td colspan="7">Applications</td></tr><tr><td></td><td>IMU</td><td>GPS</td><td>LIDAR</td><td>Camera</td><td>DG payload weights</td><td>Cost</td><td>Large area</td><td>Small area</td><td>Mobility</td><td>Weather limitation</td><td>DG accuracy (3DRMS)</td><td>Cyber c... | <table><tr><td>Platform</td><td colspan="6">System</td><td colspan="7">Applications</td></tr><tr><td>Helicopter</td><td>MEMS</td><td>hase</td><td>es</td><td>Digital</td><td>0 kg</td><td></td><td>o</td><td>s</td><td>High</td><td>Low</td><td>0 cm</td><td>es</td><td>gh</td></tr></table> |
8e3dfd8ae9d185571aa6fdc80f58d59fc7693710d1965ea81cb81606ee0b065c.png | simple | <table><tr><td></td><td>N voxels</td><td>Gray Matter</td><td>White Matter</td><td>CSF</td><td>MD</td><td>axial</td><td>FA</td><td>FW</td><td>radial</td></tr><tr><td>CSF</td><td>117049</td><td>0.1321 ± 0.2485</td><td>0.0044 ± 0.0423</td><td>0.7580 ± 0.2926</td><td>0.0018 ± 0.0009</td><td>0.0022 ±... | <table><tr><td></td><td>N voxels</td><td>Gray Matter</td><td>White Matter</td><td>CSF</td><td>MD</td><td>axial</td><td>FA</td><td>FW</td><td>radial</td></tr></table> | <table><tr><td>CSF</td><td>117049</td><td>0.1321 ± 0.2485</td><td>0.0044 ± 0.0423</td><td>0.7580 ± 0.2926</td><td>0.0018 ± 0.0009</td><td>0.0022 ± 0.0011</td><td>0.2046 ± 0.1257</td><td>0.4511 ± 0.2221</td><td>0.0015 ± 0.0008</td></tr><tr><td>Gray matter</td><td>256549</td><td>0.7724 ± 0.2988</td><td>0.1024 ± 0.2260</t... |
94f93407cf4152a63b2a7c6d1f8fd9a26a79f9897e39955b793846cc0bae489d.png | complex | <table><tr><td rowspan="2">Factors</td><td colspan="3">ANC</td><td colspan="3">Delivery</td></tr><tr><td colspan="3">N = 315</td><td colspan="3">N = 315</td></tr><tr><td></td><td>AOR (95% CI)</td><td>P-value<sup>*</sup></td><td>P-value<sup>**</sup></td><td>AOR (95% CI)</td><td>P-value<sup>*</sup></td><td>P-value<sup>**... | <table><tr><td rowspan="2">Factors</td><td colspan="3">ANC</td><td colspan="3">Delivery</td></tr><tr><td colspan="3">N = 315</td><td colspan="3">N = 315</td></tr><tr><td></td><td>AOR (95% CI)</td><td>P-value*</td><td>P-value**</td><td>AOR (95% CI)</td><td>P-value*</td><td>P-value**</td></tr><tr><td>Age group of women: ... | <table><tr><td rowspan="2">Factors</td><td colspan="3">ANC</td><td colspan="3">Delivery</td></tr><tr><td colspan="3">N = 315</td><td colspan="3">N = 315</td></tr><tr><td></td><td>AOR (95% CI)</td><td>P-value*</td><td>P-value**</td><td>AOR (95% CI)</td><td>P-value*</td><td>P-value**</td></tr><tr><td>Referral status: ref... |
a208841c966cab6abf3e19feb4bacf05e2e3660d5e87fc86ef22af07cb66e18d.png | simple | <table><tr><td></td><td>Recipient</td><td>Donor</td></tr><tr><td>Male (%)</td><td>37 (74%)</td><td>36 (72%)</td></tr><tr><td>Female (%)</td><td>13 (26%)</td><td>14 (28%)</td></tr><tr><td>Age (yrs)</td><td>51.3 ± 11.1 (16 - 67)</td><td>53.2 ± 17.2 (19 - 86)</td></tr><tr><td>BMI (kg/m<sup>2</sup>)</td><td>25.7 ... | <table><tr><td></td><td>Recipient</td></tr><tr><td>Male (%)</td><td>37 (74%)</td></tr><tr><td>Female (%)</td><td>13 (26%)</td></tr><tr><td>Age (yrs)</td><td>51.3 ± 11.1 (16 - 67)</td></tr><tr><td>BMI (kg/m2)</td><td>25.7 ± 4.73 (16.6 - 42.9)</td></tr><tr><td>MELD</td><td>21 ± 10.4 (6 - 40)</td></tr><tr><td>RRT before T... | <table><tr><td>Donor</td></tr><tr><td>36 (72%)</td></tr><tr><td>14 (28%)</td></tr><tr><td>53.2 ± 17.2 (19 - 86)</td></tr><tr><td>24.3 ± 3.3 (16.0- 31.0)</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td></td><... |
1909e8ec8fa321238d89b5b3ffaffa5bab0ff3572d8f612275431d2e2c39f90a.png | complex | <table><tr><td> </td><td colspan="2">No. of points</td></tr><tr><td>Risk factor</td><td>SITS SICH risk score</td><td>Extended risk score</td></tr><tr><td>Aspirin + clopidogrel</td><td>3</td><td>3</td></tr><tr><td>Aspirin monotherapy</td><td>2</td><td>2</td></tr><tr><td>NIHSS ≥13</td><td>2</td><td>2</td></tr><tr><... | <table><tr><td></td><td colspan="2">No. of points</td></tr><tr><td>Risk factor</td><td>SITS SICH risk score</td><td>Extended risk score</td></tr><tr><td>Aspirin + clopidogrel</td><td>3</td><td>3</td></tr><tr><td>Aspirin monotherapy</td><td>2</td><td>2</td></tr><tr><td>NIHSS ≥13</td><td>2</td><td>2</td></tr><tr><td>NIHS... | <table><tr><td></td><td colspan="2">No. of points</td></tr><tr><td>Risk factor</td><td>SITS SICH risk score</td><td>Extended risk score</td></tr><tr><td> blood pressure ≥146 mm Hg</td><td></td><td>1</td></tr><tr><td>Weight ≥95 kg</td><td>1</td><td>1</td></tr><tr><td>Onset-to-treatment time ≥180 min</td><td>1</td><td>1<... |
002f6ac944299a46ab1e94ec1c99f5c9cd7a27237f9fdc25f1b8e09b1110b163.png | complex | <table><tr><td rowspan="2">Variable</td><td colspan="2">Level of knowledge</td><td rowspan="2">COR (95% CI)</td><td rowspan="2">AOR (95% CI)</td></tr><tr><td>Adequate</td><td>Inadequate</td></tr><tr><td>Age</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> 15–24</td><td>53 (57%)</td><td>40 (43%)</td><td><... | <table><tr><td rowspan="2">Variable</td><td>Level of knowledge</td></tr><tr><td>Adequate</td></tr><tr><td>Age</td><td></td></tr><tr><td>15–24</td><td>53 (57%)</td></tr><tr><td>25–35</td><td>115 (64.2%)</td></tr><tr><td>36–45</td><td>31 (54.4%)</td></tr><tr><td>>45</td><td>9 (22%)</td></tr><tr><td>Marital status</td><td... | <table><tr><td>Level of knowledge</td><td rowspan="2">COR (95% CI)</td><td rowspan="2">AOR (95% CI)</td></tr><tr><td>Inadequate</td></tr><tr><td></td><td></td><td></td></tr><tr><td>40 (43%)</td><td>4.711 (2.022, 10.976)</td><td>1.253 (0.364, 4.319)</td></tr><tr><td>64 (35.8%)</td><td>6.389 (2.870, 14.221)</td><td>2.740... |
a5162ee77a6b42d28d3df1d309a4652f5689c6f288b1b0e690313ab895f19c5a.png | complex | <table><tr><td rowspan="2"></td><td>IL-1</td><td>IL-6</td><td>TNF-α</td><td>IL-10</td><td>TGF-β1</td></tr><tr><td colspan="5">pg/mg</td></tr><tr><td>NC</td><td>10.3 ± 1.2 *</td><td>12.5 ± 2.1 *</td><td>20.7 ± 2.3 *</td><td>265.8 ± 17.9</td><td>16.4 ± 1.8</td></tr><tr><td>SS24</td><td>... | <table><tr><td rowspan="2"></td><td>IL-1</td><td>IL-6</td><td>TNF-α</td><td>IL-10</td><td>TGF-β1</td></tr><tr><td colspan="5">pg/mg</td></tr><tr><td>NC</td><td>10.3 ± 1.2 *</td><td>12.5 ± 2.1 *</td><td>20.7 ± 2.3 *</td><td>265.8 ± 17.9</td><td>16.4 ± 1.8</td></tr><tr><td>S</td><td>9</td><td>1275</td><td>80</td><td>235.... | <table><tr><td rowspan="2"></td><td>IL-1</td><td>IL-6</td><td>TNF-α</td><td>IL-10</td><td>TGF-β1</td></tr><tr><td colspan="5">pg/mg</td></tr><tr><td>S24</td><td>2.6 ± 4.5</td><td>.6 ± 18.3</td><td>.4 ± 3.4</td><td>± 4.1</td><td></td></tr><tr><td>SA24</td><td>44.3 ± 2.6 #</td><td>662.3 ± 13.5 #</td><td>42.9 ± 1.9 #</td>... |
7e44d073201f65a4fb00b65e8f860671fa8b5b87427882f2e0784e99177c672e.png | complex | <table><tr><td>Treatment</td><td>Flume number</td><td>Field name</td></tr><tr><td>Sustainable intensification</td><td>6</td><td>Golden Rove</td></tr><tr><td rowspan="2">Increased use of legumes</td><td>8</td><td>Higher Wyke Moor and Middle Wyke Moor (reseeding in 2013)</td></tr><tr><td>11</td><td>Dairy East</td></tr><t... | <table><tr><td>Treatment</td><td>Flume number</td><td>Field name</td></tr><tr><td>Sustainable intensification</td><td>6</td><td>Golden Rove</td></tr><tr><td rowspan="2">Increased use of legumes</td><td>8</td><td>Higher Wyke Moor and Middle Wyke Moor (reseeding in 2013)</td></tr><tr><td>11</td><td>Dairy East</td></tr><t... | <table><tr><td rowspan="2">Planned reseeding</td><td></td><td>ty</td></tr><tr><td>15</td><td>Longlands East (reseeding in 2013)</td></tr></table> |
b5c26992ea8abefba4ab097d94b16db1a2f43d222a27d46ef5d343f2fcbf8b29.png | simple | <table><tr><td>Characteristics</td><td>Count (%)</td></tr><tr><td>Sociodemographic</td><td> </td></tr><tr><td> Gender</td><td> </td></tr><tr><td>Male</td><td>98 (65.3)</td></tr><tr><td>Female</td><td>52 (34.7)</td></tr><tr><td> Age (years)</td><td> </td></tr><tr><td>20–30</td><td>80 (53.3)</td></tr><tr><td>31R... | <table><tr><td>Characteristics</td><td>Count (%)</td></tr><tr><td>Sociodemographic</td><td></td></tr><tr><td>Gender</td><td></td></tr><tr><td>Male</td><td>98 (65.3)</td></tr><tr><td>Female</td><td>52 (34.7)</td></tr><tr><td>Age (years)</td><td></td></tr><tr><td>20–30</td><td>80 (53.3)</td></tr><tr><td>31–40</td><td>48 ... | <table><tr><td>Characteristics</td><td>Count (%)</td></tr><tr><td>41–50</td><td>22 (14.7)</td></tr><tr><td>Education level</td><td></td></tr><tr><td>Vocational school</td><td>58 (38.7)</td></tr><tr><td>Diploma or equivalent</td><td>62 (41.3)</td></tr><tr><td>Bachelor degree or higher</td><td>30 (20.0)</td></tr><tr><td>... |
e2615be9ada0aa4ca0c92f4a685ee175c237987fa073ef611ddffc4a347183eb.png | complex | <table><tr><td>Variable</td><td colspan="3"><i>PIK3CA </i>mutations (n = 113)</td><td colspan="3"><i>PIK3CA </i>amplification (n = 131)</td></tr><tr><td></td><td>Yes</td><td>No</td><td><i>P</i></td><td>Yes</td><td>No</td><td><i>P</i></td></tr><tr><td>No.of patients</td><td>8</td><td>105</td><td></td><td>88</td><td>43</... | <table><tr><td>Variable</td><td colspan="3">PIK3CA mutations (n = 113)</td></tr><tr><td></td><td>Yes</td><td>No</td><td>P</td></tr><tr><td>No.of patients</td><td>8</td><td>105</td><td></td></tr><tr><td>Gender</td><td></td><td></td><td></td></tr><tr><td>Male</td><td>5</td><td>82</td><td>0.57</td></tr><tr><td>Female</td>... | <table><tr><td colspan="3">PIK3CA amplification (n = 131)</td></tr><tr><td>Yes</td><td>No</td><td>P</td></tr><tr><td>88</td><td>43</td><td></td></tr><tr><td></td><td></td><td></td></tr><tr><td>68</td><td>34</td><td>0.82</td></tr><tr><td>20</td><td>9</td><td></td></tr><tr><td></td><td></td><td></td></tr><tr><td>58.6</td... |
1c17c2ea151d2c646b33db8266d461a3995c51413504838d9a12b98d404f3d1a.png | simple | <table><tr><td></td><td></td><td>Parametric</td><td>Nonparametric</td></tr><tr><td>Misacylation</td><td></td><td></td><td></td></tr><tr><td></td><td>COVE</td><td>68*</td><td>55</td></tr><tr><td></td><td>resCOVE</td><td>64</td><td>64</td></tr><tr><td></td><td>Spacer</td><td>55</td><td>64</td></tr><tr><td></td><td>Usage<... | <table><tr><td></td><td></td><td>Parametric</td><td>Nonparametric</td></tr><tr><td>Misacylation</td><td></td><td></td><td></td></tr><tr><td></td><td>COVE</td><td>68*</td><td>55</td></tr></table> | <table><tr><td></td><td>resCOVE</td><td>64</td><td>64</td></tr><tr><td></td><td>Spacer</td><td>55</td><td>64</td></tr><tr><td></td><td>Usage</td><td>38</td><td>48</td></tr><tr><td>COVERes COVE</td><td></td><td></td><td></td></tr><tr><td></td><td>Spacer</td><td>46</td><td>46</td></tr><tr><td></td><td></td><td>64</td><td... |
a45c37e33058ebf82522814c0ece62f49f789789919f674ff905b9a195fcf997.png | simple | <table><tr><td> Age/sex</td><td>Comorbidity</td><td>Site</td><td>Culture source</td><td>Therapy</td><td>Outcome</td></tr><tr><td>75/F</td><td>Syringomyelia</td><td>L leg</td><td>Tissue</td><td>Antibiotics, debridement</td><td>Survived</td></tr><tr><td>80/F</td><td>None</td><td>R leg</td><td>Tissue</td><td>Antibiotics, ... | <table><tr><td>Age/sex</td><td>Comorbidity</td><td>Site</td><td>Culture source</td><td>Therapy</td><td>Outcome</td></tr><tr><td>75/F</td><td>Syringomyelia</td><td>L leg</td><td>Tissue</td><td>Antibiotics, debridement</td><td>Survived</td></tr><tr><td>80/F</td><td>None</td><td>R leg</td><td>Tissue</td><td>Antibiotics, d... | <table><tr><td>Age/sex</td><td>Comorbidity</td><td>Site</td><td>Culture source</td><td>Therapy</td><td>Outcome</td></tr><tr><td>2/M</td><td>Vascular/lymphatic malformation</td><td>Perineum</td><td>Tissue/stool</td><td>Antibiotics, debridement</td><td>Survived</td></tr></table> |
637a6dc81162c285552953fbad6b3d1706491c111e2e6e1d01f9baa062404bc2.png | complex | <table><tr><td>Outcome</td><td colspan="4">All births</td></tr><tr><td></td><td><i>n</i></td><td>Rate</td><td>OR (95% CI)</td><td>AOR<sup>a</sup> (95% CI)</td></tr><tr><td colspan="5">Umbilical artery pH < 7.10</td></tr><tr><td> Occiput posterior</td><td>56</td><td>5.5</td><td>1.48 (1.12–1.96)</td><td>1.28 (0.... | <table><tr><td>Outcome</td><td colspan="4">All births</td></tr><tr><td></td><td>n</td><td>Rate</td><td>OR (95% CI)</td><td>AORa (95% CI)</td></tr><tr><td colspan="5">Umbilical artery pH < 7.10</td></tr><tr><td>Occiput posterior</td><td>56</td><td>5.5</td><td>1.48 (1.12–1.96)</td><td>1.28 (0.93–1.74)</td></tr><tr><td>Oc... | <table><tr><td>Outcome</td><td colspan="4">All births</td></tr><tr><td></td><td>n</td><td>Rate</td><td>OR (95% CI)</td><td>AORa (95% CI)</td></tr><tr><td colspan="5">Neonatal care</td></tr><tr><td>Occiput posterior</td><td>38</td><td>2.9</td><td>1.87 (1.33–2.62)</td><td>1.68 (1.17–2.42)</td></tr><tr><td>Occiput anterio... |
a96298098c08dbab3dafb5154396a269dc0b908c335542cfb44f71f61f712da0.png | complex | <table><tr><td rowspan="2">Ages (years)</td><td>Mild/NVI</td><td colspan="2">Low vision</td><td colspan="3">Blindness</td><td rowspan="2">Total VI (%)</td></tr><tr><td>0</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td></tr><tr><td>6–18</td><td>20.8</td><td>1.8</td><td>0.3</td><td>0.8)</td><td>1.5</td><td>0.... | <table><tr><td rowspan="2">Ages (years)</td><td>Mild/NVI</td><td colspan="2">Low vision</td><td colspan="2">Blindness</td></tr><tr><td>0</td><td>1</td><td>2</td><td>3</td><td>4</td></tr><tr><td>6–18</td><td>20.8</td><td>1.8</td><td>0.3</td><td>0.8)</td><td>1.5</td></tr><tr><td>19–35</td><td>18.8</td><td>2.5</td><td>0.0... | <table><tr><td>Blindness</td><td rowspan="2">Total VI (%)</td></tr><tr><td>5</td></tr><tr><td>0.0</td><td>4.3</td></tr><tr><td>1.8</td><td>6.3</td></tr><tr><td>1.0</td><td>9.5</td></tr><tr><td>1.8</td><td>15.8</td></tr><tr><td>4.5</td><td>35.8</td></tr></table> |
a5fc90b839b1269cebe1653f7f3775a8e48fa30234c464c3148c50d5bcc25edc.png | complex | <table><tr><td>Material</td><td>Scaffold Preparation</td><td>Shape and Structure of the Scaffold</td><td>Mechanical Properties of the Scaffold</td><td>Ref.</td></tr><tr><td>Collagen</td><td rowspan="3">Freeze drying</td><td>Sponges L = 11, 23 or 51 mm94% porosity, pore size = 62 μm</td><td>For L = 23 mm spec. EM =... | <table><tr><td>Material</td><td>Scaffold Preparation</td><td>Shape and Structure of the Scaffold</td><td>Mechanical Properties of the Scaffold</td><td>Ref.</td></tr><tr><td>Collagen</td><td rowspan="3">Freeze drying</td><td>Sponges L = 11, 23 or 51 mm94% porosity, pore size = 62 μm</td><td>For L = 23 mm spec. EM = 0.02... | <table><tr><td>n</td><td>usion</td><td>ter = 137 μm</td><td>eter 215 μm → EM = 19.3 MPaFiber diameter 137 μm → EM = 46.2 MPa</td><td>]</td></tr><tr><td>Collagen</td><td rowspan="2">ELAC</td><td>Collagen thread diameter = 50–100 μm</td><td>ND</td><td>[33]</td></tr><tr><td>Collagen</td><td>Woven collagen scaffold with 81... |
37049550b9607c9e6a41ec3afeb97cb59a8d36efbca9d93b505f99a66b755f0a.png | complex | <table><tr><td>Demographic characteristics</td><td>Sampled frequency, <i>n</i> (%)</td><td>Weight misperception frequency, <i>n</i> (%)</td></tr><tr><td colspan="3">Sex<sup>a</sup></td></tr><tr><td> Female</td><td>2003 (44.5)</td><td>426 (21.4)</td></tr><tr><td> Male</td><td>2380 (55.5)</td><td>900 (39.1)</td></tr><tr>... | <table><tr><td>Demographic characteristics</td><td>Sampled frequency, n (%)</td><td>Weight misperception frequency, n (%)</td></tr><tr><td colspan="3">Sexa</td></tr><tr><td>Female</td><td>2003 (44.5)</td><td>426 (21.4)</td></tr><tr><td>Male</td><td>2380 (55.5)</td><td>900 (39.1)</td></tr><tr><td colspan="3">Race/ethnic... | <table><tr><td>Demographic characteristics</td><td>Sampled frequency, n (%)</td><td>Weight misperception frequency, n (%)</td></tr><tr><td>9th</td><td>1120 (26.4)</td><td>376 (35.6)</td></tr><tr><td>10th</td><td>1129 (26.6)</td><td>357 (30.7)</td></tr><tr><td>11th</td><td>1152 (24.3)</td><td>330 (30.2)</td></tr><tr><td... |
566b4857a6446e18d3e132fbfe46679cf41156cbeb955474287d7628400eaadc.png | complex | <table><tr><td rowspan="2">Factors</td><td colspan="2">Univariate analysis</td><td colspan="2">Multivariate analysis</td></tr><tr><td>Hazard ratio (95% CI)</td><td><i>P</i> value</td><td>Hazard ratio (95% CI)</td><td><i>P</i> value</td></tr><tr><td>DDA1</td><td>2.747 (1.405–5.372)</td><td>0.003</td><td></td><td>0... | <table><tr><td rowspan="2">Factors</td><td colspan="2">Univariate analysis</td><td colspan="2">Multivariate analysis</td></tr><tr><td>Hazard ratio (95% CI)</td><td>P value</td><td>Hazard ratio (95% CI)</td><td>P value</td></tr><tr><td>DDA1</td><td>2.747 (1.405–5.372)</td><td>0.003</td><td></td><td>0.005</td></tr><tr><t... | <table><tr><td>Positive LN number</td><td>2.094 (1.112–3.944)</td><td>0.022</td><td></td><td><0.001</td></tr><tr><td>AJCC stage</td><td>4.42 (2.257–8.656)</td><td><0.001</td><td>4.281 (2.186–8.384)</td><td><0.001</td></tr><tr><td>Histological grade</td><td>1.142 (0.574–2.272)</td><td>0.706</td><td></td><td>0.996</td></... |
b28ba28726d00d2c7c1db28d7c2be2a92b0a6484f195136d06998d0365698255.png | simple | <table><tr><td></td><td>Men (n = 58)</td><td>Women (n = 65)</td><td>ANOVA</td><td><i>F</i></td><td><i>p</i></td></tr><tr><td>Bench press</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Pre</td><td>68.7 ± 16.0§</td><td>29.2 ± 6.3</td><td>Group</td><td>378.14</td><td>< 0.001</td></tr><tr><... | <table><tr><td></td><td>Men (n = 58)</td><td>Women (n = 65)</td><td>ANOVA</td><td>F</td><td>p</td></tr><tr><td>Ben</td><td></td><td></td><td></td><td></td><td></td></tr></table> | <table><tr><td>ch press</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Pre</td><td>68.7 ± 16.0§</td><td>29.2 ± 6.3</td><td>Group</td><td>378.14</td><td>< 0.001</td></tr><tr><td>Post</td><td>79.8 ± 15.4§*</td><td>36.9 ± 6.9*</td><td>Time</td><td>820.58</td><td>< 0.001</td></tr><tr><td>Δ%</td><td>+16.2</td... |
d5ca076dd19f65dc48935f07e96bfff873ded8386a7bbee0b92b78798b9f81b7.png | simple | <table><tr><td>Task</td><td>Group description</td><td>Activity of group 1 higher that group 2</td><td>Activity of group 1 low that group 2</td><td>Reference</td></tr><tr><td>Tactile stimulation</td><td>PD patients (1) vs. healthy control volunteers</td><td>R. primary sensory, R. motor cortex, R. supplementary motor are... | <table><tr><td>Task</td><td>Group description</td><td>Activity of group 1 higher that group 2</td></tr><tr><td>Tactile stimulation</td><td>PD patients (1) vs. healthy control volunteers</td><td>R. primary sensory, R. motor cortex, R. supplementary motor area, B. caudate, B. precuneus, B. occipital visual cortex, L. and... | <table><tr><td>Activity of group 1 low that group 2</td><td>Reference</td></tr><tr><td></td><td>(23)</td></tr><tr><td></td><td>(26)</td></tr><tr><td></td><td>(24)</td></tr><tr><td></td><td>(28, 29)</td></tr><tr><td>B. insula, B. posterior cingulate cortex, L inferior frontal cortex</td><td>(27)</td></tr><tr><td></td><t... |
2cb20b9e8e2d9a817fb7331e9dbe92fe350d81c4f26033d0ae812358ef7ba7d5.png | complex | <table><tr><td colspan="4">Motor nerve conduction</td></tr><tr><td>Nerve</td><td>Latency</td><td>Amplitude</td><td>Conduction velocity</td></tr><tr><td>Median R (wrist)</td><td>8.9 ms</td><td>1.3 mV</td><td> </td></tr><tr><td>Median R (elbow)</td><td>18.5 ms</td><td>0.8 mV</td><td>24 m/s</td></tr><tr><td>Ulnar R (wrist... | <table><tr><td colspan="4">Motor nerve conduction</td></tr><tr><td>Nerve</td><td>Latency</td><td>Amplitude</td><td>Conduction velocity</td></tr><tr><td>Median R (</td><td>8</td><td>1.3</td><td></td></tr></table> | <table><tr><td>wrist)</td><td>.9 ms</td><td> mV</td><td></td></tr><tr><td>Median R (elbow)</td><td>18.5 ms</td><td>0.8 mV</td><td>24 m/s</td></tr><tr><td>Ulnar R (wrist)</td><td>4.4 ms</td><td>6.9 mV</td><td></td></tr><tr><td>Ulnar R (below elbow)</td><td>10.4 ms</td><td>5.7 mV</td><td>38 m/s</td></tr><tr><td>Ulnar R (... |
8d61aa2c014ac5e098d184d82b3bb5a7ed708e8850c5cbd6a46f921fcb7f1600.png | complex | <table><tr><td></td><td>R-cases (<i>n</i> = 20)</td><td>6mo-cases (<i>n</i> = 19)<sup>a</sup></td><td>TST+ (<i>n</i> = 9)</td><td>TST− (<i>n</i> = 18)</td></tr><tr><td>Median age, years (range)</td><td>31.5 (17–65)</td><td>30 (18–69)</td><td>42 (20–65)</td><td>22.5 (16–51)</td></tr><tr><td... | <table><tr><td></td><td>R-cases (n = 20)</td><td>6mo-cases (n = 19)a</td><td>TST+ (n = 9)</td><td>TST− (n = 18)</td></tr><tr><td>Median age, years (range)</td><td>31.5 (17–65)</td><td>30 (18–69)</td><td>42 (20–65)</td><td>22.5 (16–51)</td></tr><tr><td>Female sex, n (%)</td><td>5 (25)</td><td>6 (23)</td><td>8 (89)</td><... | <table><tr><td>l, n (%)</td><td>6 (30)</td><td>7 (36.8)</td><td>N/A</td><td>N/A</td></tr><tr><td>neg, n (%)</td><td>1 (5)</td><td>2 (10.5)</td><td>N/A</td><td>N/A</td></tr><tr><td colspan="5">Chest X-ray gradec</td></tr><tr><td>3, n (%)</td><td>14 (70)</td><td>14 (73.7)</td><td>N/A</td><td>N/A</td></tr><tr><td>2, n (%)... |
88b36a23e66931081c344444c3fb40df93c2deb2edc939161eb7be321a4cf4e1.png | complex | <table><tr><td></td><td colspan="6">No. of abnormalities</td></tr><tr><td>Abnormality</td><td>Arctic</td><td>Innoko</td><td>Kenai</td><td>Tetlin</td><td>Yukon Delta</td><td>Total</td></tr><tr><td colspan="7">Eye abnormality</td></tr><tr><td> Anophthalmia (missing eye)</td><td>0</td><td>2</td><td>12</td><td>6</td><td>0<... | <table><tr><td></td><td>No. of abnormalities</td></tr><tr><td>Abnormality</td><td>Arctic</td></tr><tr><td colspan="2">Eye abnormality</td></tr><tr><td>Anophthalmia (missing eye)</td><td>0</td></tr><tr><td>Unpigmented iris (black eye)</td><td>0</td></tr><tr><td>Microphthalmia (small eye)</td><td>0</td></tr><tr><td>Other... | <table><tr><td colspan="5">No. of abnormalities</td></tr><tr><td>Innoko</td><td>Kenai</td><td>Tetlin</td><td>Yukon Delta</td><td>Total</td></tr><tr><td colspan="5">Eye abnormality</td></tr><tr><td>2</td><td>12</td><td>6</td><td>0</td><td>20</td></tr><tr><td>15</td><td>118</td><td>20</td><td>1</td><td>154</td></tr><tr><... |
642db7628587a733ed3fe500cc1d5f713eca9b980cd2af18dedbe1a000c5984c.png | complex | <table><tr><td rowspan="2">Source</td><td colspan="3">Minerals</td><td colspan="5">Vitamins</td></tr><tr><td>Fe (%)</td><td>Na (%)</td><td>Se (%)</td><td>Riboflavin (%)</td><td>Thiamin (%)</td><td>B12 (%)</td><td>Niacin (%)</td><td>Folic acid (%)</td></tr><tr><td>Red meat<sup>*</sup></td><td>14.5</td><td>13.9</td><td>2... | <table><tr><td rowspan="2">Source</td><td colspan="3">Minerals</td><td colspan="2">Vitamins</td></tr><tr><td>Fe (%)</td><td>Na (%)</td><td>Se (%)</td><td>Riboflavin (%)</td><td>Thiamin (%)</td></tr><tr><td>Red meat*</td><td>14.5</td><td>13.9</td><td>25.5</td><td>16.4</td><td>5.4</td></tr><tr><td>White meat</td><td>2.9<... | <table><tr><td colspan="3">Vitamins</td></tr><tr><td>B12 (%)</td><td>Niacin (%)</td><td>Folic acid (%)</td></tr><tr><td>50.6</td><td>32.6</td><td>4.4</td></tr><tr><td>4.1</td><td>11.5</td><td>4.6</td></tr><tr><td>0</td><td>4.1</td><td>21.6</td></tr><tr><td>0</td><td>0.29</td><td>7.1</td></tr><tr><td>35.1</td><td>13.9</... |
a45fb7f3c79f88c8532b79cffb19ce4456e5d823861d9668b33b65c6aa68824e.png | complex | <table><tr><td></td><td colspan="4">pCR prediction(n = 488)</td></tr><tr><td>Prediction evaluation*</td><td>PPV (SD)</td><td>NPV (SD)</td><td>Sensitivity (SD)</td><td>Specificity (SD)</td></tr><tr><td>Unsupervised clustering</td><td></td><td></td><td></td><td></td></tr><tr><td>BRmet50</td><td>93(14)</td><td>34(3)</td><... | <table><tr><td></td><td colspan="3">pCR prediction(n = 488)</td></tr><tr><td>Prediction evaluation*</td><td>PPV (SD)</td><td>NPV (SD)</td><td>Sensitivity (SD)</td></tr><tr><td>Unsupervised clustering</td><td></td><td></td><td></td></tr><tr><td>BRmet50</td><td>93(14)</td><td>34(3)</td><td>58(3)</td></tr><tr><td>PMID1827... | <table><tr><td>pCR prediction(n = 488)</td></tr><tr><td>Specificity (SD)</td></tr><tr><td></td></tr><tr><td>83(0.6)</td></tr><tr><td>83(6)</td></tr><tr><td></td></tr><tr><td>83(6)</td></tr><tr><td>67(0.5)</td></tr></table> |
c8f338df17f2aab37fb1e201b8f6350242d962be64308e1f769dc8d57f67faba.png | simple | <table><tr><td>SNP ID</td><td>Chr 16 position sequence</td><td>Sequence</td><td>Type</td><td>Amino acid change</td></tr><tr><td>rs200158701</td><td>70680854(+)</td><td>CCATGC/TCCCGG</td><td>mis</td><td>PS</td></tr><tr><td>rs192337001</td><td>70680866(+)</td><td>GCTTCA/CCCTGG</td><td>mis</td><td>TP</td></tr><tr><td>rs13... | <table><tr><td>SNP ID</td><td>Chr 16 position sequence</td><td>Sequence</td><td>Type</td><td>Amino acid change</td></tr><tr><td>rs200158701</td><td>70680854(+)</td><td>CCATGC/TCCCGG</td><td>mis</td><td>PS</td></tr><tr><td>rs192337001</td><td>70680866(+)</td><td>GCTTCA/CCCTGG</td><td>mis</td><td>TP</td></tr><tr><td>rs13... | <table><tr><td>rs372998917</td><td>70694041(+)</td><td>CTCCAC/TGGGCT</td><td>mis</td><td>TM</td></tr><tr><td>rs370436386</td><td>70690927(+)</td><td>TGCCAC/TTGAGT</td><td>mis</td><td>TL</td></tr><tr><td>rs144427482</td><td>70690571(+)</td><td>CCAACG/ATCACC</td><td>mis</td><td>IV</td></tr><tr><td>rs201108464</td><td>706... |
f41d9718c98a01ba275ff51a6abfea57ab68b73d44d3f94413a05bea76814250.png | complex | <table><tr><td rowspan="2">Groups</td><td>Total cholesterol </td><td>LDL-C</td><td>HDL-C</td><td>TG</td><td>HbA1c</td><td>FBG</td></tr><tr><td><i>r </i>Pearson</td><td><i>r </i>Pearson</td><td><i>r </i>Pearson</td><td><i>r </i>Pearson</td><td><i>r </i>Pearson</td><td><i>r </i>Pearson</td></tr><tr><td>Ox-LDL of normoalb... | <table><tr><td>Grou</td><td>Total</td><td>LD</td><td>HDL-C</td><td>TG</td><td>Hb</td><td></td></tr></table> | <table><tr><td rowspan="2">ps</td><td> cholesterol</td><td>L-C</td><td></td><td></td><td>A1c</td><td>FBG</td></tr><tr><td>r Pearson</td><td>r Pearson</td><td>r Pearson</td><td>r Pearson</td><td>r Pearson</td><td>r Pearson</td></tr><tr><td>Ox-LDL of normoalbuminurics</td><td>−0.07</td><td>−0.085</td><td>−0.25</td><td>−0... |
563e267b35a2b55907de85900b91fd35753e25ba53bb7132bf4aaa4011b9ff5f.png | simple | <table><tr><td> </td><td>Survivors(<i>n</i> = 90)</td><td>Former prisoners(<i>n</i> = 83)</td><td><i>Statistics</i></td><td>Descendants of survivors(<i>n</i> = 97)</td><td>Descendants of former prisoners(<i>n</i> = 90)</td><td><i>Statistics</i></td></tr><tr><td>Gender % <i>(n)</i></td><td> </td><td> </td><td> </td><td>... | <table><tr><td></td><td>Survivors(n = 90)</td><td>Former prisoners(n = 83)</td></tr><tr><td>Gender % (n)</td><td></td><td></td></tr><tr><td>Male</td><td>28.9 (26)</td><td>90.2 (74)</td></tr><tr><td>Female</td><td>71.1 (64)</td><td>9.8 (8)</td></tr><tr><td>Age</td><td>51.6 (10.3, 30–77)</td><td>53.9 (7.9, 34–81)</td></t... | <table><tr><td>Statistics</td><td>Descendants of survivors(n = 97)</td><td>Descendants of former prisoners(n = 90)</td><td>Statistics</td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td>χ2(1,172) = 66.4***</td><td>43.3 (42)</td><td>50.5 (46)</td><td>n.s.</td></tr><tr><td></td><td>56.7 (55)</td><td>49.5 (45)</... |
eba539bee38f1eb538c25b683833873476807032134086b155854e72a8bcda4a.png | simple | <table><tr><td>SSA</td><td>ST</td><td>t<sub>1</sub>(h)</td><td>μ<sub>e</sub></td><td>STD</td><td>ξ</td><td>STD</td><td>γ</td><td>t<sub>1</sub>(h)</td><td>μ<sub>e</sub></td><td>STD<sup>a</sup></td><td>ξ</td><td>STD</td><td>γ</td></tr><tr><td>3.37</td><td>53.95</td><td>6</td><td>−3.12<... | <table><tr><td>SSA</td><td>ST</td><td>t1(h)</td><td>μe</td><td>STD</td><td>ξ</td><td>STD</td><td>γ</td><td>t1(h)</td><td>μe</td><td>STDa</td><td>ξ</td><td>STD</td><td>γ</td></tr><tr><td>3.37</td><td>53.95</td><td>6</td><td>−3.12</td><td>−0.05</td><td>−31.92</td><td>−0.04</td><td>48.93</td><td>36</td><td>−2.38</td><td>1... | <table><tr><td>SSA</td><td>ST</td><td>t1(h)</td><td>μe</td><td>STD</td><td>ξ</td><td>STD</td><td>γ</td><td>t1(h)</td><td>μe</td><td>STDa</td><td>ξ</td><td>STD</td><td>γ</td></tr><tr><td></td><td>42.78</td><td></td><td>−3.33</td><td>−0.54</td><td>−34.17</td><td>−0.54</td><td>47.59</td><td></td><td>−3.72</td><td>−1.50</t... |
052f5788b8f24869a2850e1d6e9fac1d83e6b15612b2103bebe80cdd5cb8a7f4.png | simple | <table><tr><td></td><td>ABFAB</td><td>FBC</td><td>FPH</td><td>Total</td></tr><tr><td>Women who stopped breastfeeding before 6 months</td><td>n = 65</td><td>n = 7</td><td>n = 14</td><td>n = 86</td></tr><tr><td>Stopped bf before mastitis</td><td>5</td><td>1</td><td>2</td><td>8</td></tr><tr><td>Stopped within 3 wks</td><t... | <table><tr><td></td></tr><tr><td>Women who stopped breastfeeding before 6 months</td></tr><tr><td>Stopped bf before mastitis</td></tr><tr><td>Stopped within 3 wks</td></tr><tr><td>Stopped between 3 and 26 wks</td></tr><tr><td>Women breastfeeding at 6 months</td></tr><tr><td>Mastitis in previous 3 wks</td></tr><tr><td>M... | <table><tr><td>ABFAB</td><td>FBC</td><td>FPH</td><td>Total</td></tr><tr><td>n = 65</td><td>n = 7</td><td>n = 14</td><td>n = 86</td></tr><tr><td>5</td><td>1</td><td>2</td><td>8</td></tr><tr><td>29</td><td>2</td><td>5</td><td>36*</td></tr><tr><td>31</td><td>4</td><td>7</td><td>42</td></tr><tr><td>n = 70</td><td>n = 19</t... |
3646d7c795e184da4148f18c3ff8046272010a472a993df2af9be8ab292814d3.png | complex | <table><tr><td></td><td>Patients</td><td>Controls</td><td>OR*</td><td>95%CI</td><td>OR**</td><td>95%CI</td></tr><tr><td colspan="7">rs117813469</td></tr><tr><td> GG</td><td>186</td><td>198</td><td></td><td></td><td></td><td></td></tr><tr><td> GC/CC</td><td>28</td><td>15</td><td>2.25</td><td>(1.14-4.46)</td><td>2.12</td... | <table><tr><td></td><td>Patients</td><td>Controls</td><td>OR*</td><td>95%CI</td><td>OR**</td><td>95%CI</td></tr><tr><td colspan="7">rs117813469</td></tr><tr><td>GG</td><td>186</td><td>198</td><td></td><td></td><td></td><td></td></tr><tr><td>GC/CC</td><td>28</td><td>15</td><td>2.25</td><td>(1.14-4.46)</td><td>2.12</td><... | <table><tr><td></td><td>Patients</td><td>Controls</td><td>OR*</td><td>95%CI</td><td>OR**</td><td>95%CI</td></tr><tr><td>TT</td><td>189</td><td>189</td><td></td><td></td><td></td><td></td></tr><tr><td>TC/CC</td><td>25</td><td>24</td><td>2.53</td><td>(1.33-4.82)</td><td>2.32</td><td>(1.24-4.34)</td></tr><tr><td colspan="... |
6a8d2828d9e7d00e12a7059fb53253c67fd2d531c90266b08e00e280dfccae21.png | simple | <table><tr><td></td><td>Pencil</td><td>Oil-pastel</td><td>Gouache</td><td><i>F</i><sup>(2,98)</sup></td></tr><tr><td></td><td>(M/SD)</td><td>(M/SD)</td><td>(M/SD)</td><td></td></tr><tr><td>RSA</td><td>6.23 (± 1.07)</td><td>5.90 (± 0.98)</td><td>6.01 (± 1.09)</td><td>3.58<sup>∗</sup></td></tr><tr><t... | <table><tr><td></td><td>Pencil</td><td>Oil-pastel</td><td>Gouache</td><td>F(2,98)</td></tr><tr><td></td><td>(M/SD)</td><td>(M/SD)</td><td>(M/SD)</td><td></td></tr></table> | <table><tr><td>RSA</td><td>6.23 (± 1.07)</td><td>5.90 (± 0.98)</td><td>6.01 (± 1.09)</td><td>3.58∗</td></tr><tr><td>ΔRSA</td><td>-0.11 (± 0.57)</td><td>-0.49 (± 0.62)</td><td>-0.33 (± 0.65)</td><td>5.97∗∗</td></tr><tr><td>CSI</td><td>2.85 (± 0.14)</td><td>3.04 (± 0.13)</td><td>2.83 (± 0.13)</td><td>0.017</td></tr><tr><... |
69035cec5af991caff3f85c0fef1045b3b7e50472b9adffe537ca5f600d11224.png | simple | <table><tr><td>Protein ID</td><td>Orthologs</td><td>Potential functions</td></tr><tr><td>Wolco1| 166770</td><td>STE20</td><td>Growth, virulence, and sclerotial formation</td></tr><tr><td>Wolco1| 43954</td><td>STE11</td><td>Growth, virulence, and sclerotial formation</td></tr><tr><td>Wolco1| 150169</td><td>STE7</td><td>... | <table><tr><td>Protein ID</td></tr><tr><td>Wolco1| 166770</td></tr><tr><td>Wolco1| 43954</td></tr><tr><td>Wolco1| 150169</td></tr><tr><td>Wolco1| 75024</td></tr><tr><td>Wolco1| 144702</td></tr><tr><td>Wolco1| 135363</td></tr><tr><td>Wolco1| 121529</td></tr></table> | <table><tr><td>Orthologs</td><td>Potential functions</td></tr><tr><td>STE20</td><td>Growth, virulence, and sclerotial formation</td></tr><tr><td>STE11</td><td>Growth, virulence, and sclerotial formation</td></tr><tr><td>STE7</td><td>Growth, virulence, and sclerotial formation</td></tr><tr><td>MKK2</td><td>Regulate MAPK... |
7c9c890d2795eee22c44942bb1d093b7317890e32860b2064085cf37c25ab724.png | simple | <table><tr><td> </td><td>Group A<sup>†</sup>(n = 255)</td><td>Group B<sup>‡</sup>(n = 41)</td><td>p-value</td></tr><tr><td>Mean sUA level (mg/dL)</td><td>4.69 ± 1.08</td><td>7.61 ± 0.95</td><td>< 0.001</td></tr><tr><td>F/U time (months)</td><td>73.0 ± 42.2</td><td>62.0 ± 46.8</td><td>... | <table><tr><td></td><td>Group A†(n = 255)</td><td>Group B‡(n = 41)</td><td>p-value</td></tr><tr><td>Mean sUA level (mg/dL)</td><td>4.69 ± 1.08</td><td>7.61 ± 0.95</td><td>< 0.001</td></tr><tr><td>F/U time (months)</td><td>73.0 ± 42.2</td><td>62.0 ± 46.8</td><td>0.134</td></tr><tr><td>Initial eGFR (mL/min/1.73 m2)</td><... | <table><tr><td></td><td>Group A†(n = 255)</td><td>Group B‡(n = 41)</td><td>p-value</td></tr><tr><td>mL/min/1.73 m2)</td><td>.9</td><td>.3 ± 31.7</td><td>< 0.001</td></tr><tr><td>ΔeGFR (mL/min/1.73 m2/yr)</td><td>−0.29 ± 4.22</td><td>−1.87 ± 3.30</td><td>0.026</td></tr><tr><td>ΔeGFR (%/yr)</td><td>−0.72 ± 6.03</td><td>−... |
8b348ae8b1b777e848c7eb91106ccebfa5cf70a5c9f9e4d55f3d309a420b0056.png | complex | <table><tr><td rowspan="2">HPV type</td><td colspan="2">Baseline (<i>n</i> = 1759)</td><td colspan="2">Follow-up (<i>n</i> = 85)</td></tr><tr><td><i>N</i></td><td>Prevalence (%)</td><td><i>N</i></td><td>Persistence (%)</td></tr><tr><td>Any type</td><td>152</td><td>8.64</td><td>29/85</td><td>34.12</td></tr><tr><td>High-... | <table><tr><td rowspan="2">HPV type</td><td colspan="2">Baseline (n = 1759)</td><td colspan="2">Follow-up (n = 85)</td></tr><tr><td>N</td><td>Prevalence (%)</td><td>N</td><td>Persistence (%)</td></tr><tr><td>Any type</td><td>152</td><td>8.64</td><td>29/85</td><td>34.12</td></tr><tr><td>High-risk</td><td>131</td><td>7.4... | <table><tr><td>HPV53</td><td>1</td><td>0.06</td><td>0/1</td><td>0.00</td></tr><tr><td>HPV55</td><td>2</td><td>0.11</td><td>0/0</td><td>-</td></tr><tr><td>HPV61</td><td>13</td><td>0.74</td><td>4/8</td><td>50.00</td></tr><tr><td>HPV82</td><td>4</td><td>0.23</td><td>0/1</td><td>0.00</td></tr></table> |
599eccd4e92c96d38a535c3c4542ac9239b49b9345a844f4d30ad261a3207a0e.png | complex | <table><tr><td>Individual subject characteristics</td><td>Prognostic factors</td><td></td></tr><tr><td></td><td>Age</td><td>Confirmatory</td></tr><tr><td></td><td>Gender</td><td>Exploratory</td></tr><tr><td></td><td>Height, weight, body mass index</td><td>Exploratory</td></tr><tr><td></td><td>Ethnicity/race</td><td>Exp... | <table><tr><td>Individual subject characteristics</td><td>Prognostic factors</td></tr><tr><td></td><td>Age</td></tr><tr><td></td><td>Gender</td></tr><tr><td></td><td>Height, weight, body mass index</td></tr><tr><td></td><td>Ethnicity/race</td></tr><tr><td colspan="2">Lifestyle factors</td></tr><tr><td></td><td>Particip... | <table><tr><td></td></tr><tr><td>Confirmatory</td></tr><tr><td>Exploratory</td></tr><tr><td>Exploratory</td></tr><tr><td>Exploratory</td></tr><tr><td>Lifestyle factors</td></tr><tr><td>Exploratory</td></tr><tr><td>Exploratory</td></tr><tr><td>Exploratory</td></tr><tr><td>Sociodemographic characteristics</td></tr><tr><t... |
bf79e5230e27ba89b20107a4990b5d1cde206cee0fc7834a6e06362ebb781c03.png | complex | <table><tr><td>Systems</td><td>Plot area (m<sup>2</sup>)</td><td>Gradient (°)</td><td>Aspect</td><td>Agro type (by Chinese system)</td><td>Bulk density (g cm<sup>−3</sup>)</td><td>pH</td><td>OM (g kg<sup>−1</sup>)</td><td>TN (g kg<sup>−1</sup>)</td><td>AN (g kg<sup>−1</sup>)</td><td>TP (g k... | <table><tr><td>Systems</td><td>Plot area (m2)</td><td>Gradient (°)</td><td>Aspect</td><td>Agro type (by Chinese system)</td><td>Bulk density (g cm−3)</td><td>pH</td><td>OM (g kg−1)</td><td>TN (g kg−1)</td><td>AN (g kg−1)</td><td>TP (g kg−1)</td><td>AP (g kg−1)</td></tr><tr><td>S1</td><td>56</td><td>6.3</td><td>NE36°</t... | <table><tr><td>S3</td><td>52</td><td>5.8</td><td>NE60°</td><td>Purple soil</td><td>1.48</td><td>6.11</td><td>39.66</td><td>2.44</td><td>0.166</td><td>0.36</td><td>0.001</td></tr></table> |
643298bc18e3a0f00727bd49828afa6697ec7b56576bd71d95b85e0279e1dcac.png | simple | <table><tr><td></td><td>B</td><td>SE</td><td>Significance</td></tr><tr><td>(Constant)</td><td>−0.57</td><td>0.05</td><td></td></tr><tr><td>City of residence</td><td>0.25</td><td>0.06</td><td>0.000*</td></tr><tr><td>Smoker(s) present in the home</td><td>0.12</td><td>0.07</td><td>0.073</td></tr></table> | <table><tr><td></td><td>B</td><td>SE</td><td>Significance</td></tr><tr><td>(Constant)</td><td>−0.57</td><td>0.05</td><td></td></tr><tr><td>City of residence</td><td>0.25</td><td>0.06</td><td>0.000*</td></tr></table> | <table><tr><td>Smoker(s) present in the home</td><td>0.12</td><td>0.07</td><td>0.073</td></tr></table> |
58e42727741c5fc90aa109083b40670346939d542eecfeeca1416e21ca6d9deb.png | complex | <table><tr><td rowspan="2">Year</td><td rowspan="2">No. of Samples</td><td rowspan="2">No. of Positive</td><td rowspan="2">Positive Rate (%)</td><td colspan="3">Influenza A Virus</td><td rowspan="2">Influenza B Virus</td></tr><tr><td>H1N1</td><td>H3N2</td><td>pdm H1N1</td></tr><tr><td>2006</td><td>1290</td><td>145</td>... | <table><tr><td rowspan="2">Year</td><td rowspan="2">No. of Samples</td><td rowspan="2">No. of Positive</td><td rowspan="2">Positive Rate (%)</td><td colspan="3">Influenza A Virus</td><td rowspan="2">Influenza B Virus</td></tr><tr><td>H1N1</td><td>H3N2</td><td>pdm H1N1</td></tr><tr><td>2006</td><td>1290</td><td>145</td>... | <table><tr><td rowspan="2">Year</td><td rowspan="2">No. of Samples</td><td rowspan="2">No. of Positive</td><td rowspan="2">Positive Rate (%)</td><td colspan="3">Influenza A Virus</td><td rowspan="2">Influenza B Virus</td></tr><tr><td>H1N1</td><td>H3N2</td><td>pdm H1N1</td></tr><tr><td>2013</td><td>1658</td><td>69</td><... |
763f28988f8d671b242c1522a410a769bbb86ef50ef4dc9668d33ba12edd7068.png | simple | <table><tr><td></td><td>Total, n= 1781</td><td>Wild-type <i>KRAS</i>, n= 1416</td><td>Mutant <i>KRAS</i>, n= 365</td><td>P</td></tr><tr><td>No. of associated alterations</td><td></td><td></td><td></td><td></td></tr><tr><td> Median (range)</td><td>0 (0-9)</td><td>0(0-9)</td><td>1(1-9)</td><td><0.0001</td></tr><tr><td... | <table><tr><td></td><td>Total, n= 1781</td><td>Wild-type KRAS, n= 1416</td><td>Mutant KRAS, n= 365</td><td>P</td></tr><tr><td>No. of associated alterations</td><td></td><td></td><td></td><td></td></tr><tr><td>Median (range)</td><td>0 (0-9)</td><td>0(0-9)</td><td>1(1-9)</td><td><0.0001</td></tr><tr><td>>2</td><td>118</t... | <table><tr><td>Type of associated alterations</td><td></td><td></td><td></td><td></td></tr><tr><td>PI3KCA</td><td>162/1386 (12%)</td><td>118/1203 (10%)</td><td>44/183 (24%)</td><td><0.0001</td></tr><tr><td>P53</td><td>184/510 (36%)</td><td>155/427 (36%)</td><td>29/83 (35%)</td><td>0.87</td></tr><tr><td>PTEN</td><td>132... |
43f85e59472e23bb5bf407049cf64438e3c653957561252e125e645f680f847e.png | complex | <table><tr><td rowspan="2">Tumor Response as per RECIST v1.1</td><td>Arm A, <i>N</i> = 3</td><td>Arm B, <i>N</i> = 5</td></tr><tr><td>Number of patients</td><td>Number of patients</td></tr><tr><td>CR</td><td>0</td><td>0</td></tr><tr><td>PR</td><td>0</td><td>0</td></tr><tr><td>SD</td><td>1</td><td>2</td></tr><tr><td>PD<... | <table><tr><td rowspan="2">Tumor Response as per RECIST v1.1</td><td>Arm A, N = 3</td><td>Arm B, N = 5</td></tr><tr><td>Number of patients</td><td>Number of patients</td></tr><tr><td>CR</td><td>0</td><td>0</td></tr><tr><td>PR</td><td>0</td><td>0</td></tr><tr><td>SD</td><td>1</td><td>2</td></tr></table> | <table><tr><td>PD</td><td>2</td><td>3</td></tr></table> |
de0faa79dbcf7e8985d2eee38ded9875d967b30b6eeb05f295f3fbed4817235a.png | simple | <table><tr><td>Number of eligible patients</td><td>420</td><td>Type of procedure</td></tr><tr><td>Primary procedures</td><td>196</td><td>Aesthetic</td></tr><tr><td><i>n</i> = 378</td><td>131</td><td>Aesthetic and functional</td></tr><tr><td></td><td>51</td><td>Functional</td></tr><tr><td>Revision procedures</td><td>31<... | <table><tr><td>Number of eligible patients</td><td>420</td><td>Type of procedure</td></tr><tr><td>Primary procedures</td><td>196</td><td>Aesthetic</td></tr></table> | <table><tr><td>n = 378</td><td>131</td><td>Aesthetic and functional</td></tr><tr><td></td><td>51</td><td>Functional</td></tr><tr><td>Revision procedures</td><td>31</td><td>Aesthetic</td></tr><tr><td>n = 42</td><td>9</td><td>Aesthetic and functional</td></tr><tr><td></td><td>2</td><td>Functional</td></tr></table> |
b794f34c2276014168e3eba3b280481fc01cb399a605d34ae3df9b61fddc5eae.png | complex | <table><tr><td rowspan="2">Incubation medium [Fe] (mM)</td><td colspan="2">Measured MR relaxation times</td><td colspan="2">Cell function assays</td></tr><tr><td><i>T</i><sub>1</sub> (ms)</td><td><i>T</i><sub>2</sub> (ms)</td><td>Viability (%)</td><td>Proliferation (%)</td></tr><tr><td>0</td><td>2166 ± 135</td><td... | <table><tr><td rowspan="2">Incubation medium [Fe] (mM)</td><td colspan="2">Measured MR relaxation times</td><td colspan="2">Cell function assays</td></tr><tr><td>T1 (ms)</td><td>T2 (ms)</td><td>Viability (%)</td><td>Proliferation (%)</td></tr><tr><td>0</td><td>2166 ± 135</td><td>85.7 ± 9.0</td><td>100 ± 14</td><td>100 ... | <table><tr><td>0.009</td><td>828 ± 127</td><td>12.6 ± 0.6</td><td>96 ± 15</td><td>96 ± 19</td></tr><tr><td>0.018</td><td>613 ± 65</td><td>11.3 ± 0.6</td><td>95 ± 13</td><td>89 ± 12</td></tr><tr><td>0.036</td><td>630 ± 60</td><td>10.9 ± 0.5</td><td>86 ± 16</td><td>84 ± 15</td></tr></table> |
e4ea7f48434798783f64766449c6ba70aabe8c613aaf523472d6f66a87e2eb59.png | simple | <table><tr><td></td><td>No.</td><td>%</td></tr><tr><td>Gender</td><td></td><td></td></tr><tr><td> Male</td><td>59</td><td>54.13</td></tr><tr><td> Female</td><td>50</td><td>45.87</td></tr><tr><td>Chemotherapy</td><td></td><td></td></tr><tr><td> Gemcitabine alone</td><td>41</td><td>37.61</td></tr><tr><td> Gemcitabine com... | <table><tr><td></td><td>No.</td><td>%</td></tr><tr><td>Gender</td><td></td><td></td></tr><tr><td>Male</td><td>59</td><td>54.13</td></tr><tr><td>Female</td><td>50</td><td>45.87</td></tr><tr><td>Chemotherapy</td><td></td><td></td></tr><tr><td>Gemcitabine alone</td><td>41</td><td>37.61</td></tr><tr><td>Gemcitabine combine... | <table><tr><td></td><td>No.</td><td>%</td></tr><tr><td></td><td></td><td>2</td></tr><tr><td>Unknown</td><td>29</td><td>26.61</td></tr><tr><td>Distant metastasis</td><td></td><td></td></tr><tr><td>Liver</td><td>50</td><td>71.43</td></tr><tr><td>Lung</td><td>2</td><td>2.86</td></tr><tr><td>bone</td><td>4</td><td>5.71</td... |
96c58a2e05c0abda624f057eca277c8d1d6dbfdeb61951498067069ae2dbd20e.png | complex | <table><tr><td>Characteristic</td><td></td><td>Number (<i>n</i>)</td><td>Percentage (%)</td></tr><tr><td rowspan="2">Gender</td><td>Male</td><td>155</td><td>55</td></tr><tr><td>Female</td><td>127</td><td>45</td></tr><tr><td rowspan="2">Gestational age (weeks)</td><td>28–36</td><td>115</td><td>41</td></tr><tr><td>... | <table><tr><td>Characteristic</td><td></td><td>Number (n)</td><td>Percentage (%)</td></tr><tr><td></td><td>M</td><td></td><td>5</td></tr></table> | <table><tr><td>Characteristic</td><td></td><td>Number (n)</td><td>Percentage (%)</td></tr><tr><td rowspan="2">Gender</td><td>ale</td><td>155</td><td>5</td></tr><tr><td>Female</td><td>127</td><td>45</td></tr><tr><td rowspan="2">Gestational age (weeks)</td><td>28–36</td><td>115</td><td>41</td></tr><tr><td>≥37–42</td><td>... |
03742c6ae71558770725399ebce166fe97a1cc073a8b397847d2ac94b3fefbbf.png | complex | <table><tr><td rowspan="2">Ash sample</td><td colspan="5">Fraction</td><td rowspan="2">Total</td><td rowspan="2">Total independent measurment</td></tr><tr><td>Water soluble</td><td>Acid soluble/exchangeable</td><td>Reducible</td><td>Oxidizable</td><td>Entrapped in parent matter</td></tr><tr><td>A</td><td>0.0008</td><td... | <table><tr><td rowspan="2">Ash sample</td><td colspan="5">Fraction</td><td rowspan="2">Total</td><td rowspan="2">Total independent measurment</td></tr><tr><td>Water soluble</td><td>Acid soluble/exchangeable</td><td>Reducible</td><td>Oxidizable</td><td>Entrapped in parent matter</td></tr><tr><td>A</td><td>0.0008</td><td... | <table><tr><td rowspan="2">Ash sample</td><td colspan="5">Fraction</td><td rowspan="2">Total</td><td rowspan="2">Total independent measurment</td></tr><tr><td>Water soluble</td><td>Acid soluble/exchangeable</td><td>Reducible</td><td>Oxidizable</td><td>Entrapped in parent matter</td></tr><tr><td>C</td><td>0.0016</td><td... |
6b9b89bdb6892532107600973423ebe4178a13891a8dc77fe4472812e2141a48.png | simple | <table><tr><td>Variable</td><td>Adjusted odds ratio (95% CI)</td><td>SE</td></tr><tr><td>CGPA</td><td>15.27 [6.28, 27.11]<sup><i>∗∗∗</i></sup></td><td>0.88</td></tr><tr><td>Age <30 years</td><td>0.31 [0.06, 1.63]</td><td>0.85</td></tr><tr><td>Male gender</td><td>1.13 [0.50, 2.55]</td><td>0.42</td><... | <table><tr><td>Variable</td><td>Adjusted odds ratio (95% CI)</td><td>SE</td></tr><tr><td>CGPA</td><td>15.27 [6.28, 27.11]∗∗∗</td><td>0.88</td></tr><tr><td>Age <30 years</td><td>0.31 [0.06, 1.63]</td><td>0.85</td></tr><tr><td>Male gender</td><td>1.13 [0.50, 2.55]</td><td>0.42</td></tr><tr><td>Home residence (ref = rural... | <table><tr><td>Variable</td><td>Adjusted odds ratio (95% CI)</td><td>SE</td></tr><tr><td>City/urban</td><td>1.44 [0.38, 5.42]</td><td>0.68</td></tr><tr><td>Father highly educated</td><td>0.56 [0.21, 1.49]</td><td>0.49</td></tr><tr><td>Mother highly education</td><td>1.23 [0.55, 2.76]</td><td>0.41</td></tr><tr><td>Enter... |
c82458e7963c5b5e5a5d30b2651fc8dee50b893dc079c05752090ebcb5a05b41.png | simple | <table><tr><td>Gene names</td><td>RS</td><td>Gene names</td><td>RS</td><td>Gene names</td><td>RS</td></tr><tr><td>KRT19</td><td>1.6</td><td>PTGES2</td><td>0.4</td><td>BCL7C</td><td>0.2</td></tr><tr><td>BARD1</td><td>1.6</td><td>PREX2</td><td>0.4</td><td>ZNF18</td><td>0.2</td></tr><tr><td>MST1R</td><td>1.5</td><td>USP1<... | <table><tr><td>Gene names</td><td>RS</td><td>Gene names</td><td>RS</td><td>Gene names</td></tr><tr><td>KRT19</td><td>1.6</td><td>PTGES2</td><td>0.4</td><td>BCL7C</td></tr><tr><td>BARD1</td><td>1.6</td><td>PREX2</td><td>0.4</td><td>ZNF18</td></tr><tr><td>MST1R</td><td>1.5</td><td>USP1</td><td>0.4</td><td>PGLS</td></tr><... | <table><tr><td>RS</td></tr><tr><td>0.2</td></tr><tr><td>0.2</td></tr><tr><td>0.2</td></tr><tr><td>0.2</td></tr><tr><td>0.2</td></tr><tr><td>0.2</td></tr><tr><td>0.1</td></tr><tr><td>0.1</td></tr><tr><td>0.1</td></tr><tr><td>0.1</td></tr><tr><td>0.1</td></tr><tr><td>0.1</td></tr><tr><td>0.1</td></tr><tr><td>0.1</td></tr... |
adbb04ef5956e742cab0ffb40adf8c2a71e269bc373ef950751315ba02587913.png | complex | <table><tr><td></td><td colspan="2">SNP-database region</td><td></td><td></td></tr><tr><td>Scan-statistic region</td><td>Inter-gene</td><td>Within-gene</td><td>Regions detected only by scan statistic</td><td>Total no. regions</td></tr><tr><td>Non-gene scan statistic</td><td>33 (8)<sup>a</sup></td><td>0</td><td>72 (12)<... | <table><tr><td></td><td colspan="2">SNP-database region</td><td></td><td></td></tr><tr><td>Scan-statistic region</td><td>Inter-gene</td><td>Within-gene</td><td>Regions detected only by scan statistic</td><td>Total no. regions</td></tr><tr><td>Non-gene scan statistic</td><td>33 (8)a</td><td>0</td><td>72 (12)</td><td>105... | <table><tr><td>Gene scan statistic</td><td>10 (7)</td><td>38 (17)</td><td>87 (20)</td><td>135 (44)</td></tr><tr><td>Total</td><td>43 (15)</td><td>38 (17)</td><td>159 (32)</td><td>240 (64)</td></tr></table> |
ebb370375814fc09449cebacbd5fa0242e6084ca67c5f80994b8ef23b0830b53.png | complex | <table><tr><td>Reference</td><td>Country</td><td>Study design</td><td>Sample size</td><td>Data source/sample type</td><td colspan="2">Results</td></tr><tr><td rowspan="3">[30]</td><td rowspan="3">China</td><td rowspan="3">The 5th Chinese National Nutrition and Health Survey (2010–2012)</td><td rowspan="3">2111</t... | <table><tr><td>Reference</td><td>Country</td><td>Study design</td><td>Sample size</td><td>Data source/sample type</td><td>Results</td></tr><tr><td rowspan="3">[30]</td><td rowspan="3">China</td><td rowspan="3">The 5th Chinese National Nutrition and Health Survey (2010–2012)</td><td rowspan="3">2111</td><td rowspan="3">... | <table><tr><td>Results</td></tr><tr><td>A decreased risk of MetS with higher Mn intake.</td></tr><tr><td>An increased risk of MetS with higher Mn intake.</td></tr><tr><td>Mn intake was inversely associated with abdominal obesity and hypertriacylglycerolaemia in men, but positively associated with low HDL-cholesterol in... |
3c950692aabca1421775793445d1b9f1ee1370c495db218d31cc0b239c1c956b.png | simple | <table><tr><td>Theme</td><td>Number of mode-sensitive* items of total number of items</td><td>Median (and maximum)odds ratio among mode-sensitive items</td></tr><tr><td><i>Health behaviour</i></td><td></td><td></td></tr><tr><td>Medicine</td><td>0/3</td><td>-</td></tr><tr><td>Smoking habits</td><td>0/1</td><td>-</td></t... | <table><tr><td>Theme</td><td>Number of mode-sensitive* items of total number of items</td></tr><tr><td>Health behaviour</td><td></td></tr><tr><td>Medicine</td><td>0/3</td></tr><tr><td>Smoking habits</td><td>0/1</td></tr><tr><td>Self assessments</td><td></td></tr><tr><td>Self-esteem</td><td>8/9</td></tr><tr><td>Well-bei... | <table><tr><td>Median (and maximum)odds ratio among mode-sensitive items</td></tr><tr><td></td></tr><tr><td>-</td></tr><tr><td>-</td></tr><tr><td></td></tr><tr><td>1.57 (2.57)</td></tr><tr><td>1.55 (2.20)</td></tr><tr><td>2.12 (2.21)</td></tr><tr><td>1.67 (2.44)</td></tr></table> |
01ca6ef05de6969f22c167f644c0a988150c11f69cda0378f41cedcb8570a567.png | complex | <table><tr><td></td><td>Total</td><td>No education</td><td>Primary</td><td>Secondary</td><td>Some college or more</td><td>Ratio: No ed vs. Some college or more</td></tr><tr><td colspan="7">Diabetes</td></tr><tr><td> 1998</td><td>3.72 (3.62, 3.83)</td><td>3.88 (3.65,4.12)</td><td>3.99 (3.84,4.14)</td><td>2.81 (2.48,3.13... | <table><tr><td></td><td>Total</td><td>No education</td><td>Primary</td><td>Secondary</td><td>Some college or more</td><td>Ratio: No ed vs. Some college or more</td></tr><tr><td colspan="7">Diabetes</td></tr><tr><td>1998</td><td>3.72 (3.62, 3.83)</td><td>3.88 (3.65,4.12)</td><td>3.99 (3.84,4.14)</td><td>2.81 (2.48,3.13)... | <table><tr><td></td><td>Total</td><td>No education</td><td>Primary</td><td>Secondary</td><td>Some college or more</td></tr><tr><td>overall change</td><td>−2.75</td><td>−3.44</td><td>−2.37</td><td>−2.22</td><td>−0.81</td></tr></table> |
ed9aeec297a9ef3b747f930b8fe3cfbed7e00e8ca0e3333c6264111908e5d351.png | complex | <table><tr><td> </td><td colspan="4">Risk of bias</td><td colspan="3">Applicability concerns concerns</td></tr><tr><td>First author, year</td><td>Patient selection</td><td>Index test</td><td>Reference standard</td><td>Flow and timing</td><td>Patient selection</td><td>Index test</td><td>Reference standard</td></tr><tr><... | <table><tr><td></td><td colspan="4">Risk of bias</td><td colspan="2">Applicability concerns concerns</td></tr><tr><td>First author, year</td><td>Patient selection</td><td>Index test</td><td>Reference standard</td><td>Flow and timing</td><td>Patient selection</td><td>Index test</td></tr><tr><td>Beldame, 2011 [23]</td><t... | <table><tr><td>Applicability concerns concerns</td></tr><tr><td>Reference standard</td></tr><tr><td>+</td></tr><tr><td>+</td></tr><tr><td>+</td></tr><tr><td>+</td></tr><tr><td>+</td></tr><tr><td>+</td></tr><tr><td>+</td></tr><tr><td>+</td></tr><tr><td>+</td></tr><tr><td>+</td></tr><tr><td>+</td></tr><tr><td>+</td></tr>... |
530157c1a3be3e6a31db27e656665615eee0510c2808d205b2d53102651e6ad8.png | complex | <table><tr><td>Tumor stage</td><td><i>N</i></td><td>(%)</td></tr><tr><td>Non-invasive carcinoma</td><td>24</td><td>8.7</td></tr><tr><td colspan="3"><i>Invasive carcinoma</i></td></tr><tr><td>T1</td><td>176</td><td>61.9</td></tr><tr><td>T2</td><td>63</td><td>22.1</td></tr><tr><td>T3</td><td>9</td><td>3.0</td></tr><tr><t... | <table><tr><td>Tumor stage</td><td>N</td><td>(%)</td></tr><tr><td>Non-invasive carcinoma</td><td>24</td><td>8.7</td></tr></table> | <table><tr><td>Tumor stage</td><td>N</td><td>(%)</td></tr><tr><td colspan="3">Invasive carcinoma</td></tr><tr><td>T1</td><td>176</td><td>61.9</td></tr><tr><td>T2</td><td>63</td><td>22.1</td></tr><tr><td>T3</td><td>9</td><td>3.0</td></tr><tr><td>T4</td><td>8</td><td>3.0</td></tr><tr><td>Unknown</td><td>4</td><td>1.3</td... |
2fe866da159656645f1457b16c67b4381ce93a5cb7fde6992901519cacfe9fd4.png | complex | <table><tr><td>Primers</td><td>5′–3′ sequence (bp)</td><td></td></tr><tr><td colspan="3">Primers for 3′-RACE PCR</td></tr><tr><td>Kiss1-F</td><td>CGCCACAAGCGGCCAAGAAG</td><td></td></tr><tr><td>Kiss2-F</td><td>AGGGCCACATTTCCTGCCGACT</td><td></td></tr><tr><td colspan="3">Primers for 5′-RACE ... | <table><tr><td>Primers</td><td>5′–3′ sequence (bp)</td><td></td></tr><tr><td colspan="3">Primers for 3′-RACE PCR</td></tr><tr><td>Kiss1-F</td><td>CGCCACAAGCGGCCAAGAAG</td><td></td></tr><tr><td>Kiss2-F</td><td>AGGGCCACATTTCCTGCCGACT</td><td></td></tr><tr><td colspan="3">Primers for 5′-RACE PCR</td></tr><tr><td>Kiss1-R</... | <table><tr><td>Primers</td><td>5′–3′ sequence (bp)</td></tr><tr><td>gnrh-r2-R</td><td>TTGGAAGATGCCTTCCCTTT</td></tr></table> |
edb80137ed988cabeaac52890a9029ba836e734ee694fef764cbcc7d1ec8e3b2.png | simple | <table><tr><td>Accession ID</td><td>Amplicon Size</td><td>Primers used</td></tr><tr><td>α ENaC-wt</td><td>325 bp</td><td>Sense: 5'-TCATGCTGCTACGCCGGTTCC-3'</td></tr><tr><td></td><td></td><td>Antisense:5'-TCCATCAGTTTACAAGGGAG-3'</td></tr><tr><td>α ENaC a</td><td>266 bp</td><td>Sense: 5'-CAGAGCTCCTGGGGGCGCCTT-3... | <table><tr><td>Accession ID</td><td>Amplicon Size</td><td>Primers used</td></tr><tr><td>α ENaC-wt</td><td>325 bp</td><td>Sense: 5'-TCATGCTGCTACGCCGGTTCC-3'</td></tr><tr><td></td><td></td><td>Antisense:5'-TCCATCAGTTTACAAGGGAG-3'</td></tr><tr><td>α ENaC a</td><td>266 bp</td><td>Sense: 5'-CAGAGCTCCTGGGGGCGCCTT-3'</td></tr... | <table><tr><td></td><td></td><td>Antisense: 5'-CTAGAGTAGCATAGGCAGGT-3'</td></tr><tr><td>CK475461</td><td>814 bp</td><td>Sense: 5'-TCCAAGTATACACAGCAGGT-3'</td></tr><tr><td></td><td></td><td>Antisense: 5'-TACAGGAGTCAGGCTGTGAG-3'</td></tr><tr><td>CK364785</td><td>764 bp</td><td>Sense: 5'-GGGGCTATTGCTATTATAAA-3'</td></tr><... |
e848a99bfd5e6afe3ec9a80aae8a7aadf011d081ea63755825161cd1f7c40fca.png | simple | <table><tr><td>Powders Prepared with Different Process Control Agents</td><td>Crystallite Size (nm)</td><td>Lattice Constant (Å)</td><td>Strain (%)</td></tr><tr><td>None</td><td>11.8</td><td>3.1636</td><td>0.688</td></tr><tr><td>Ethanol</td><td>24.2</td><td>3.1549</td><td>0.483</td></tr><tr><td>Stearic acid</td><... | <table><tr><td>Powders Prepared with Different Process Control Agents</td><td>Crystallite Size (nm)</td><td>Lattice Constant (Å)</td><td>Strain (%)</td></tr><tr><td>None</td><td>11.8</td><td>3.1636</td><td>0.688</td></tr><tr><td>Ethanol</td><td>24.2</td><td>3.1549</td><td>0.483</td></tr></table> | <table><tr><td>Powders Prepared with Different Process Control Agents</td><td>Crystallite Size (nm)</td><td>Lattice Constant (Å)</td><td>Strain (%)</td></tr><tr><td>Stearic acid</td><td>14.7</td><td>3.1648</td><td>0.590</td></tr></table> |
5ff12fd072b6ba73afdf9c871ff317d28c53fd77b711178c59b12db0230e7915.png | simple | <table><tr><td>Region</td><td>States</td><td>Frequency</td><td>IAQ Practice Indexb</td><td>Schools with index ≥ 70 (%)</td></tr><tr><td>1</td><td>Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont</td><td>25</td><td>71.8</td><td>64</td></tr><tr><td>2</td><td>New Jersey, New York, Puerto Rico,... | <table><tr><td>Region</td><td>States</td><td>Frequency</td><td>IAQ Practice Indexb</td><td>Schools with index ≥ 70 (%)</td></tr><tr><td>1</td><td>Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont</td><td>25</td><td>71.8</td><td>64</td></tr><tr><td>2</td><td>New Jersey, New York, Puerto Rico,c U.S.... | <table><tr><td>Region</td><td>States</td><td>Frequency</td><td>IAQ Practice Indexb</td><td>Schools with index ≥ 70 (%)</td></tr><tr><td>7</td><td>sas, Missouri, Nebraska</td><td>5</td><td>7</td><td>3</td></tr><tr><td>8</td><td>Colorado, Montana, North Dakota, South Dakota, Utah, Wyoming</td><td>13</td><td>66.3</td><td>... |
3f20548b64bc1132ce1cb62251541c28fd36b7d6c00c82cc64db87e0f0ca78a4.png | simple | <table><tr><td>Zone</td><td>2008 NBS* Est. U5sfrom 2002 Census</td><td>U5s Registered</td><td>LLINs delivered†</td><td>LLINS issued‡ (%)</td><td>U5s not receiving an LLIN**</td></tr><tr><td>Tanga</td><td>288,185</td><td>N/A††</td><td>402,448</td><td>380,458(94.5)</td><td>0‡‡</td></tr... | <table><tr><td>Zone</td><td>2008 NBS* Est. U5sfrom 2002 Census</td><td>U5s Registered</td><td>LLINs delivered†</td><td>LLINS issued‡ (%)</td><td>U5s not receiving an LLIN**</td></tr><tr><td>Tanga</td><td>288,185</td><td>N/A††</td><td>402,448</td><td>380,458(94.5)</td><td>0‡‡</td></tr></table> | <table><tr><td>South</td><td>333,571</td><td>403,594</td><td>469,644</td><td>435,112 (92.6)</td><td>3,456</td></tr><tr><td>Lake</td><td>1,457,439</td><td>1,925,372</td><td>2,107,000</td><td>2,047,889 (97.2)</td><td>65,618</td></tr><tr><td>West Lake</td><td>1,609,747</td><td>1,691,854</td><td>1,745,682</td><td>1,662,302... |
dafd2ca98ad9d1ab89951971db1cf68f8b1fc08271304ef5d003cf8eda53082d.png | complex | <table><tr><td rowspan="2">County</td><td colspan="2">Pre-treatment</td><td colspan="2">Post-treatment</td></tr><tr><td>Number of schools</td><td>Number of children</td><td>Number of schools</td><td>Number of children</td></tr><tr><td>Bomet</td><td>1</td><td>108</td><td>1</td><td>103</td></tr><tr><td>Bungoma</td><td>1<... | <table><tr><td rowspan="2">County</td><td colspan="2">Pre-treatment</td><td colspan="2">Post-treatment</td></tr><tr><td>Number of schools</td><td>Number of children</td><td>Number of schools</td><td>Number of children</td></tr><tr><td>Bomet</td><td>1</td><td>108</td><td>1</td><td>103</td></tr><tr><td>Bungoma</td><td>1<... | <table><tr><td>Taita Taveta</td><td>1</td><td>102</td><td>1</td><td>91</td></tr><tr><td>Overall</td><td>18</td><td>1899</td><td>18</td><td>1878</td></tr></table> |
2c0fdafc31416a8ee903f5d0c1b04ad424096b2f608a00351f985b23effdbdd2.png | simple | <table><tr><td></td><td>Patient 1</td><td>Patient 2</td><td>Patient 3</td></tr><tr><td>Origin</td><td>Dominican Republic</td><td>Haiti</td><td>Haiti</td></tr><tr><td>Age (years)</td><td>25</td><td>52</td><td>41</td></tr><tr><td>Sex (W/M)</td><td>W</td><td>W</td><td>M</td></tr><tr><td>Date of diagnosis (and onset of sym... | <table><tr><td></td><td>Patient 1</td><td>Patient 2</td><td>Patient 3</td></tr><tr><td>Origin</td><td>Dominican Republic</td><td>Haiti</td><td>Haiti</td></tr><tr><td>Age (years)</td><td>25</td><td>52</td><td>41</td></tr><tr><td>Sex (W/M)</td><td>W</td><td>W</td><td>M</td></tr><tr><td>Date of diagnosis (and onset of sym... | <table><tr><td>Screening for taeniasis in household</td><td>Negative</td><td>Negative</td><td>Negative</td></tr><tr><td>Treatment</td><td>Albendazole + Steroids + Valproic acid</td><td>Albendazole + Praziquantel + Steroids + Levetiracetam</td><td>Surgical removala + Albendazole + Steroids + Valproic acid</td></tr><tr><... |
545f8a9ff482173bc7bd2e568609d807dbdc5b6480bb0d8efa06ec8a539f9dea.png | complex | <table><tr><td>Domain</td><td>APH</td><td>PPH</td><td>Eclampsia</td></tr><tr><td rowspan="3">Initial assessment & diagnosis</td><td rowspan="3">Per vaginum examination (34%)</td><td rowspan="3">Exploring the uterus for blood clots (39%)</td><td>Weight (4%)</td></tr><tr><td>Swelling on body parts related to severe a... | <table><tr><td>Domain</td><td>APH</td><td>PPH</td><td>Eclampsia</td></tr><tr><td>Initial assessment & diagnosis</td><td>Per vaginum examination (34%)</td><td>Exploring the uterus for blood clots (39%)</td><td>Weight (4%)</td></tr></table> | <table><tr><td>Domain</td><td>APH</td><td>PPH</td><td>Eclampsia</td></tr><tr><td rowspan="2">Initial assessment & diagnosis</td><td rowspan="2">Per vaginum examination (34%)</td><td rowspan="2">Exploring the uterus for blood clots (39%)</td><td>Swelling on body parts related to severe anemia (8%), blurred vision relate... |
9f5329f3f783f64f8498a5e85e05656ad98514c0fa33e567ade50b60e871decb.png | simple | <table><tr><td>Pt nr.</td><td>Max IAP</td><td>Macroscopy</td><td>Microscopy</td><td>Outcome</td></tr><tr><td>1</td><td>22</td><td>Autopsy findings: Focal ischemia on serosal and mucosal side of small bowel</td><td>Mucosa of jejunum and colon almost completely disappeared</td><td>Died 2 days after admission to the ICU</... | <table><tr><td>Pt nr.</td><td>Max IAP</td><td>Macroscopy</td><td>Microscopy</td><td>Outcome</td></tr><tr><td>1</td><td>22</td><td>Autopsy findings: Focal ischemia on serosal and mucosal side of small bowel</td><td>Mucosa of jejunum and colon almost completely disappeared</td><td>Died 2 days after admission to the ICU</... | <table><tr><td>Pt nr.</td><td>Max IAP</td><td>Macroscopy</td><td>Microscopy</td><td>Outcome</td></tr><tr><td>13</td><td>32</td><td>Patchy and full ischemia of the terminal ileum; full ischemia of cecum and left colon</td><td>ischemia ileum, cecum and left colon</td><td>Discharge to ward 16 days after decompression</td>... |
409e0715612752730dc09a90bec367888cf0b4655b318dfe52f444f4e91f66ac.png | complex | <table><tr><td>Parameters</td><td>Score</td><td> </td></tr><tr><td rowspan="2">Acuteness of the first cry</td><td>Absent</td><td>0</td></tr><tr><td>Present</td><td>2</td></tr><tr><td rowspan="2">Burst rhythmicity</td><td>Absent</td><td>0</td></tr><tr><td>Present</td><td>2</td></tr><tr><td rowspan="3">Constancy of the c... | <table><tr><td>Parameters</td></tr><tr><td rowspan="2">Acuteness of the first cry</td></tr><tr></tr><tr><td rowspan="2">Burst rhythmicity</td></tr><tr></tr><tr><td rowspan="3">Constancy of the crying intensity</td></tr><tr></tr><tr></tr></table> | <table><tr><td>Score</td><td></td></tr><tr><td>Absent</td><td>0</td></tr><tr><td>Present</td><td>2</td></tr><tr><td>Absent</td><td>0</td></tr><tr><td>Present</td><td>2</td></tr><tr><td>Absent</td><td>0</td></tr><tr><td>Intermediate</td><td>1</td></tr><tr><td>Constant</td><td>2</td></tr></table> |
43f7300236f4d82723910113c4fd611177b1eaab613619144b85b581179cda8c.png | simple | <table><tr><td></td><td>Part 1 (<i>n</i> = 104)</td><td>Part 2 (<i>n</i> = 56)</td></tr><tr><td>Breed [number (%) of cats]</td><td></td><td></td></tr><tr><td>Domestic shorthair cat</td><td>85 (81.6)</td><td>46 (82.1)</td></tr><tr><td>Maine coon</td><td>6 (5.7)</td><td>3 (5.4)</td></tr><tr><td>Norwegian</td><td>4 (3.8)<... | <table><tr><td></td><td>Part 1 (n = 104)</td><td>Part 2 (n = 56)</td></tr><tr><td>Breed [number (%) of cats]</td><td></td><td></td></tr><tr><td>Domestic shorthair cat</td><td>85 (81.6)</td><td>46 (82.1)</td></tr><tr><td>Maine coon</td><td>6 (5.7)</td><td>3 (5.4)</td></tr><tr><td>Norwegian</td><td>4 (3.8)</td><td>3 (5.4... | <table><tr><td></td><td>Part 1 (n = 104)</td><td>Part 2 (n = 56)</td></tr><tr><td>Siamese</td><td>1 (0.9)</td><td>–</td></tr><tr><td>Turkish Angora Cat</td><td>1 (0.9)</td><td>–</td></tr><tr><td>British Shorthair</td><td>1 (0.9)</td><td>–</td></tr><tr><td>Gender [number (%) of cats]</td><td></td><td></td></tr><tr><td>S... |
db39edbee9c25e77b4f67440a523c3840c8c4958d75c182a4842a7918551f474.png | complex | <table><tr><td rowspan="2">Feeding Practices</td><td colspan="2">Age of Introduction of Complementary Foods</td></tr><tr><td><17 Weeks <i>n</i> (%)</td><td>≥17 Weeks <i>n</i> (%)</td></tr><tr><td>Total</td><td>395 (62.5)</td><td>237 (37.5)</td></tr><tr><td colspan="3">Explanations given for introducing solid f... | <table><tr><td rowspan="2">Feeding Practices</td><td colspan="2">Age of Introduction of Complementary Foods</td></tr><tr><td><17 Weeks n (%)</td><td>≥17 Weeks n (%)</td></tr><tr><td>Total</td><td>395 (62.5)</td><td>237 (37.5)</td></tr><tr><td colspan="3">Explanations given for introducing solid foods</td></tr><tr><td>B... | <table><tr><td rowspan="2">Feeding Practices</td><td colspan="2">Age of Introduction of Complementary Foods</td></tr><tr><td><17 Weeks n (%)</td><td>≥17 Weeks n (%)</td></tr><tr><td>Baby food manufacturers</td><td>27 (6.8)</td><td>25 (10.5)</td></tr><tr><td>Yoghurt</td><td>5 (1.3)</td><td>11 (4.6)</td></tr><tr><td>Othe... |
5d1e389cec720b66822eb8b0d59a66591621ea377ccded3b72d9792331884b98.png | complex | <table><tr><td> </td><td colspan="2">Right Knee</td><td> </td><td> </td><td colspan="2">Left Knee</td><td> </td><td> </td></tr><tr><td> </td><td>Before</td><td>After</td><td><i>P</i></td><td>Effect size</td><td>Before</td><td>After</td><td><i>P</i></td><td>Effect size</td></tr><tr><td>KIN (n = 16)</td><td>6.9 ± 1.... | <table><tr><td></td><td colspan="2">Right Knee</td><td></td><td></td><td colspan="2">Left Knee</td><td></td><td></td></tr><tr><td></td><td>Before</td><td>After</td><td>P</td><td>Effect size</td><td>Before</td><td>After</td><td>P</td><td>Effect size</td></tr><tr><td>KIN (n = 16)</td><td>6.9 ± 1.9 (5.0 – 10.0)</td><td>2.... | <table><tr><td>US (n = 12)</td><td>6.6 ± 3.0 (0.0 – 10.0)</td><td>4.5 ± 3.7a (0.0 – 10.0)</td><td>0.009</td><td>0.41</td><td>7.3 ± 2.3 (4.0 – 10.0)</td><td>3.8 ± 3.1 (0.0 – 7.0)</td><td>0.054</td><td>0.54</td></tr></table> |
79c938375298aa138f1c58fddb5c402dfd06019b15b6fc62a4801bfa52ae2c22.png | simple | <table><tr><td></td><td>Positive keywords</td><td>Negative keywords</td></tr><tr><td>BTE</td><td>mould, be34, map, gp, 92, audio, inf, be52, ref, staff, reqd, be36, contact</td><td>fta, reshel, appt, it, nn, nfa, 2001, rev, lacquer, hn, km, imp, review, 2000</td></tr><tr><td>ITE</td><td>fta, reshel, appt, it, nn, nfa, ... | <table><tr><td></td><td>Positive keywords</td><td>Negative keywords</td></tr><tr><td>BTE</td><td>mould, be34, map, gp, 92, audio, inf, be52, ref, staff, reqd, be36, contact</td><td>fta, reshel, appt, it, nn, nfa, 2001, rev, lacquer, hn, km, imp, review, 2000</td></tr><tr><td>IT</td><td>fta, reshel, appt, it,</td><td>mo... | <table><tr><td>E</td><td> nn, nfa, 2001, rev, lacquer, hn, km, imp, review, 2000, nh, vent, progress, aid, dt, taken</td><td>6, contact, tri, n, order</td></tr></table> |
681d38e2c308825a62b0b547a3d6e519e686df060c63ebf681d673941d4dc637.png | complex | <table><tr><td colspan="10">A. Regions from first iteration analyses</td></tr><tr><td colspan="3">Degree of damage to each ROI</td><td colspan="3">Analysis with Fuzzy images</td><td colspan="4">Analysis with Binary images</td></tr><tr><td>Group</td><td>Temporal ROI</td><td>Frontal ROI</td><td>n</td><td>Impaired</td><td... | <table><tr><td colspan="10">A. Regions from first iteration analyses</td></tr><tr><td colspan="3">Degree of damage to each ROI</td><td colspan="3">Analysis with Fuzzy images</td><td colspan="4">Analysis with Binary images</td></tr></table> | <table><tr><td>Group</td><td>Temporal ROI</td><td>Frontal ROI</td><td>n</td><td>Impaired</td><td>Not impaired</td><td colspan="2">n</td><td>Impaired</td><td>Not impaired</td></tr><tr><td>Frontal (1)</td><td>≤ 25%</td><td>≥ 75%</td><td>68</td><td>18</td><td>50</td><td colspan="2">77</td><td>19</td><td>58</td></tr><tr><t... |
2ad758ee4e601bd0d564f58348e4245bd0cbca8c2565c18094b1d46dc0d97098.png | complex | <table><tr><td></td><td>Age</td><td colspan="3">Southern Coastal plain(Yoto)</td><td colspan="3">Central Plateaux(Ogou)</td><td colspan="3">Northern Savannah(Tone)</td></tr><tr><td></td><td>mo</td><td>2004%</td><td>2005%</td><td>RR (95%CI)</td><td>2004%</td><td>2005%</td><td>RR (95%CI)</td><td>2004%</td><td>2005%</td><... | <table><tr><td></td><td>Age</td><td colspan="3">Southern Coastal plain(Yoto)</td><td colspan="3">Central Plateaux(Ogou)</td><td colspan="3">Northern Savannah(Tone)</td></tr><tr><td></td><td>mo</td><td>2004%</td><td>2005%</td><td>RR (95%CI)</td><td>2004%</td><td>2005%</td><td>RR (95%CI)</td><td>2004%</td><td>2005%</td><... | <table><tr><td></td><td>Age</td><td colspan="3">Southern Coastal plain(Yoto)</td><td colspan="3">Central Plateaux(Ogou)</td><td colspan="3">Northern Savannah(Tone)</td></tr><tr><td></td><td>mo</td><td>2004%</td><td>2005%</td><td>RR (95%CI)</td><td>2004%</td><td>2005%</td><td>RR (95%CI)</td><td>2004%</td><td>2005%</td><... |
df44b013f80e6e277589ff1b0478e3a3d91132aba3d80da85315c04201443f91.png | complex | <table><tr><td></td><td>+</td><td>−</td></tr><tr><td colspan="3">NEURAL ACTIVITY</td></tr><tr><td>Spontaneous activity</td><td></td><td></td></tr><tr><td> Electro-physiology</td><td>Basta and Ernst (90), Jastreboff and Sasaki (87), and Manabe et al. (91)</td><td>Ma et al. (92)</td></tr><tr><td> Metabolicmarkers</... | <table><tr><td></td><td>+</td><td>−</td></tr><tr><td colspan="3">NEURAL ACTIVITY</td></tr><tr><td>Spon</td><td></td><td></td></tr></table> | <table><tr><td></td><td>+</td><td>−</td></tr><tr><td>taneous activity</td><td></td><td></td></tr><tr><td>Electro-physiology</td><td>Basta and Ernst (90), Jastreboff and Sasaki (87), and Manabe et al. (91)</td><td>Ma et al. (92)</td></tr><tr><td>Metabolicmarkers</td><td>Paul et al. (93)</td><td>Wallhausser-Franke et al.... |
b0bf5328cb063cfee409037e3fb9d9dde8c0aee4ff87f0c2d4ff688cab9fcf32.png | complex | <table><tr><td></td><td>Baseline</td><td colspan="2">HD</td><td colspan="2">H60</td><td colspan="2">S60</td></tr><tr><td></td><td></td><td>PEG-albumin</td><td>HES</td><td>PEG-albumin</td><td>HES</td><td>PEG-albumin</td><td>HES</td></tr><tr><td>Hematocrit (%)</td><td>46.4 ± 1.4</td><td>26.4 ± 0.9*<sup>b</sup><... | <table><tr><td></td><td>Baseline</td><td colspan="2">HD</td><td colspan="2">H60</td><td colspan="2">S60</td></tr></table> | <table><tr><td></td><td></td><td>PEG-albumin</td><td>HES</td><td>PEG-albumin</td><td>HES</td><td>PEG-albumin</td><td>HES</td></tr><tr><td>Hematocrit (%)</td><td>46.4 ± 1.4</td><td>26.4 ± 0.9*b</td><td>31.6 ± 1.1*</td><td>18.2 ± 0.4*†</td><td>-</td><td>18.1 ± 0.5*†</td><td>-</td></tr><tr><td>PaO2 (mmHg)</td><td>58.9 ± 8... |
632719cc3d1a359e36170b4615329293200f40f91f48d96a914bc56cb693c9b7.png | simple | <table><tr><td></td><td>N = 134</td><td>(%)</td></tr><tr><td>Food reactions</td><td></td><td></td></tr><tr><td>Gastro-intestinal symptoms</td><td>67</td><td>(50)</td></tr><tr><td>OAS – Oral Allergy Syndrome</td><td>63</td><td>(47)</td></tr><tr><td>Difficulty breathing</td><td>53</td><td>(40)</td></tr><tr><td>Skin... | <table><tr><td></td><td>N = 134</td><td>(%)</td></tr><tr><td>Food reactions</td><td></td><td></td></tr><tr><td>Gastro-intestinal symptoms</td><td>67</td><td>(50)</td></tr><tr><td>OAS – Oral Allergy Syndrome</td><td>63</td><td>(47)</td></tr><tr><td>Difficulty breathing</td><td>53</td><td>(40)</td></tr><tr><td>Skin sympt... | <table><tr><td></td><td>19</td><td>4)</td></tr><tr><td>Food reactions during the last 12 months</td><td>60</td><td>(45)</td></tr><tr><td>Allergic diseases</td><td>100</td><td>(75)</td></tr><tr><td>Rhino conjunctivitis</td><td>69</td><td>(52)</td></tr><tr><td>Eczema</td><td>64</td><td>(48)</td></tr><tr><td>Asthma</td><t... |
11bf9951ed5e1a7f6942e1921fc6304550ebb03f5086c42e30b0ec6e602e9ebf.png | complex | <table><tr><td></td><td></td><td>Cases (%)</td><td>Controls (%)</td></tr><tr><td colspan="4">Gender</td></tr><tr><td></td><td>Male</td><td>463 (58%)</td><td>423 (53%)</td></tr><tr><td></td><td>Female</td><td>334 (42%)</td><td>370 (47%)</td></tr><tr><td colspan="4">Age group (years)</td></tr><tr><td></td><td>20-49</td><... | <table><tr><td></td><td></td><td>Cases (%)</td><td>Controls (%)</td></tr><tr><td colspan="4">Gender</td></tr><tr><td></td><td>Male</td><td>463 (58%)</td><td>423 (53%)</td></tr><tr><td></td><td>Female</td><td>334 (42%)</td><td>370 (47%)</td></tr><tr><td colspan="4">Age group (years)</td></tr><tr><td></td><td>20-49</td><... | <table><tr><td></td><td>LPL</td><td>42 (5%)</td><td>-</td></tr><tr><td></td><td>MISC BCL</td><td>71 (9%)</td><td>-</td></tr><tr><td colspan="4">T-cell lymphomas</td></tr><tr><td></td><td>MF</td><td>40 (5%)</td><td>-</td></tr><tr><td></td><td>PTCL</td><td>29 (4%)</td><td>-</td></tr><tr><td></td><td>MISC TCL</td><td>7 (1... |
6632dbe11832ab2bfb7f71c6f502a2b7c01efcf59e4c8bc368fd70b34022545f.png | complex | <table><tr><td></td><td>Number of airlines</td></tr><tr><td colspan="2">Pre-boarding arrangements</td></tr><tr><td>• Request a food “buffer zone”</td><td>5</td></tr><tr><td>• No “buffer zone”</td><td>3</td></tr><tr><td>• Request “allergen-free meal”</td><td>1</td></... | <table><tr><td></td><td>Number of airlines</td></tr><tr><td colspan="2">Pre-boarding arrangements</td></tr><tr><td>• Request a food “buffer zone”</td><td>5</td></tr><tr><td>• No “buffer zone”</td><td>3</td></tr><tr><td>• Request “allergen-free meal”</td><td>1</td></tr><tr><td rowspan="2">• Pre-boarding to wipe down sea... | <table><tr><td>• Announcements to inform customers there is a peanut or tree-nut allergic passenger on board or that peanut products will not be served</td><td>No 7</td></tr><tr><td colspan="2">Free snack policy on peanut/nut/sesame</td></tr><tr><td rowspan="2">• Serving peanuts</td><td>Yes 2</td></tr><tr><td>No 11</td... |
f2f0112bcad693a028c723e4f298815614bd21d6c0ee02112455b220fd390312.png | complex | <table><tr><td>Risk category</td><td>Criteria</td><td>Age to commence screening</td><td>Screening Test</td><td>Screening frequency (years)</td></tr><tr><td rowspan="3">Average-risk(Age-only)</td><td rowspan="3">Age 50–74 years</td><td rowspan="3">50</td><td>FOBT</td><td>2</td></tr><tr><td>Sigmoidoscopy</td><td>5<... | <table><tr><td>Risk category</td><td>Criteria</td><td>Age to commence screening</td><td>Screening Test</td><td>Screening frequency (years)</td></tr><tr><td rowspan="3">Average-risk(Age-only)</td><td rowspan="3">Age 50–74 years</td><td rowspan="3">50</td><td>FOBT</td><td>2</td></tr><tr><td>Sigmoidoscopy</td><td>5</td></... | <table><tr><td>Moderate-risk(FamilyHx)</td><td>Family history of CRC in 1 first-degree relative ≥60 years</td><td>40</td><td>Colonoscopy</td><td>10</td></tr><tr><td rowspan="2"></td><td>Family history of CRC in 1 first-degree relative < 60 years</td><td rowspan="2">40b</td><td rowspan="2">Colonoscopy</td><td rowspan="2... |
11514fae5f9423d893e803a6cf7a0eafbce74345556a552f492cca2c181a8aa0.png | complex | <table><tr><td>Targeted Gene</td><td>Primer</td><td>Sequence (5′–3′)</td></tr><tr><td rowspan="2">ALDOA</td><td>Forward</td><td>ATGCCCTACCAATATCCAGC</td></tr><tr><td>Reverse</td><td>GACAGCCCATCCAACCCT</td></tr><tr><td rowspan="2">CDC20</td><td>Forward</td><td>GGCACCAGTGATCGACACATTCGCAT</td></tr><tr><t... | <table><tr><td>Targeted Gene</td><td>Primer</td><td>Sequence (5′–3′)</td></tr><tr><td rowspan="2">ALDO</td><td>Forward</td><td>ATGCCCTACCAATATCCAGC</td></tr><tr><td>Revers</td><td>GACAGCCCATCCAAC</td></tr></table> | <table><tr><td>A</td><td>e</td><td>CCT</td></tr><tr><td rowspan="2">CDC20</td><td>Forward</td><td>GGCACCAGTGATCGACACATTCGCAT</td></tr><tr><td>Reverse</td><td>GCCATAGCCTCAGGGTCTCATCTGCT</td></tr><tr><td rowspan="2">CCNB2</td><td>Forward</td><td>GCGTTGGCATTATGGATCG</td></tr><tr><td>Reverse</td><td>TCTTCCGGGAAACTGGCTG</td... |
a270f231ac307b3e481e762cbd4de0bcc73ec2472e01530dbbbbdfd21a4f2a72.png | simple | <table><tr><td>Resistance pattern to the NARMS antimicrobial panel</td><td>% of isolates with resistance profile (no.)</td><td>Plasmid profile groups detected (no.)<sup>a</sup></td><td>Species of isolates with plasmids (no.)</td><td>PFGE patterns</td></tr><tr><td>STR, FIS, TET, SXT</td><td>33% (14)</td><td>II, X(3), VI... | <table><tr><td>Resistance pattern to the NARMS antimicrobial panel</td><td>% of isolates with resistance profile (no.)</td><td>Plasmid profile groups detected (no.)a</td><td>Species of isolates with plasmids (no.)</td><td>PFGE patterns</td></tr><tr><td>STR, FIS, TET, SXT</td><td>33% (14)</td><td>II, X(3), VIII</td><td>... | <table><tr><td>AMP, KAN, STR, FIS</td><td>2% (1)</td><td>IV</td><td>S. sonnei</td><td>XIII</td></tr><tr><td>CHL, FIS, TET, SXT</td><td>2% (1)</td><td>III</td><td>S. flexneri Y var.</td><td>XXIV</td></tr><tr><td>AMP, CHL, STR, TET</td><td>2% (1)</td><td>IX</td><td>S. flexneri 1b</td><td>XIV</td></tr><tr><td>AMP, STR, FI... |
7c76b8a59b7a860439ce9a9521cbba8fa3d773cdb5f545d589e99629573744b7.png | complex | <table><tr><td rowspan="3"></td><td colspan="5">Disability in 2012 (%)</td></tr><tr><td rowspan="2">All <i>n</i> (%)</td><td colspan="2">No FOF in 2012</td><td colspan="2">Having FOF in 2012</td></tr><tr><td>No FOF in 2010</td><td>Having FOF in 2010</td><td>No FOF in 2010</td><td>Having FOF in 2010</td></tr><tr><td>Pre... | <table><tr><td rowspan="3"></td><td colspan="5">Disability in 2012 (%)</td></tr><tr><td rowspan="2">All n (%)</td><td colspan="2">No FOF in 2012</td><td colspan="2">Having FOF in 2012</td></tr><tr><td>No FOF in 2010</td><td>Having FOF in 2010</td><td>No FOF in 2010</td><td>Having FOF in 2010</td></tr><tr><td>Prevalence... | <table><tr><td>None</td><td>21.2</td><td>6.9</td><td>22.0</td><td>26.7</td><td>50.9</td></tr><tr><td>One or more</td><td>21.2</td><td>8.6</td><td>16.1</td><td>17.3</td><td>41.9</td></tr><tr><td>Cognitive function in 2010 ††</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Normal (K-MMSE ≥ 24)</td><td>9.4 *... |
b03c671653f44c48a83b4e8791e5c4e90016519c5ac2f0417420bf69e511bbaf.png | complex | <table><tr><td></td><td colspan="2">Putative fox feces</td><td colspan="2">Locations</td></tr><tr><td></td><td>Number of samples</td><td>Positive samples (%)</td><td>Number of locations</td><td>Positive locations (%)</td></tr><tr><td>Anatolia</td><td>186</td><td>7 (3.8)</td><td>59</td><td>3 (5.1)</td></tr><tr><td>Thrac... | <table><tr><td></td><td colspan="2">Putative fox feces</td><td colspan="2">Locations</td></tr><tr><td></td><td>Number of samples</td><td>Positive samples (%)</td><td>Number of locations</td><td>Positive locations (%)</td></tr></table> | <table><tr><td>Anatolia</td><td>186</td><td>7 (3.8)</td><td>59</td><td>3 (5.1)</td></tr><tr><td>Thrace</td><td>219</td><td>1 (0.5)</td><td>114</td><td>1 (0.9)</td></tr><tr><td>Total</td><td>405</td><td>8 (1.9)</td><td>173</td><td>4 (2.3)</td></tr></table> |
ef90399023416d0219564f3273e662220ccb1d94fd7f309022532ee0de951e7e.png | complex | <table><tr><td>Characteristics</td><td>No. of patients</td><td colspan="2">Expression of CIP2A</td><td><i>P</i>value</td></tr><tr><td> </td><td> </td><td>Low, n (%)</td><td>High, n (%)</td><td> </td></tr><tr><td>Age</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>≤45</td><td>130</td><td>48 (50)</td><td>8... | <table><tr><td>Characteristics</td><td>No. of patients</td><td colspan="2">Expression of CIP2A</td><td>Pvalue</td></tr><tr><td></td><td></td><td>Low, n (%)</td><td>High, n (%)</td><td></td></tr><tr><td>Age</td><td></td><td></td><td></td><td></td></tr><tr><td>≤45</td><td>130</td><td>48 (50)</td><td>82 (45)</td><td>0.39<... | <table><tr><td>Characteristics</td><td>No. of patients</td><td colspan="2">Expression of CIP2A</td><td>Pvalue</td></tr><tr><td></td><td></td><td>Low, n (%)</td><td>High, n (%)</td><td></td></tr><tr><td>Distant metastasis</td><td></td><td></td><td></td><td></td></tr><tr><td>Yes</td><td>63</td><td>11 (11)</td><td>52 (28)... |
0065bcbd987c65f4941e449b9083469577f34870a6b3f8839911bb1c97eabce7.png | complex | <table><tr><td></td><td>Early differentiation</td><td>Intermediate differentiation</td><td>Terminal differentiation</td></tr><tr><td colspan="4">Phenotypic markers</td></tr><tr><td>CD28</td><td>++</td><td>+/−</td><td>–</td></tr><tr><td>CD27</td><td>++</td><td>+/−</td><td>–</td></tr><tr><td>CD45R... | <table><tr><td></td><td>Early differentiation</td><td>Intermediate differentiation</td><td>Terminal differentiation</td></tr><tr><td colspan="4">Phenotypic markers</td></tr><tr><td>CD28</td><td>++</td><td>+/−</td><td>–</td></tr><tr><td>CD27</td><td>++</td><td>+/−</td><td>–</td></tr><tr><td>CD45RA</td><td>++</td><td>+/−... | <table><tr><td></td><td>Early differentiation</td><td>Intermediate differentiation</td><td>Terminal differentiation</td></tr><tr><td>Cytotoxicity</td><td>–</td><td>+</td><td>++</td></tr><tr><td>Cytokine secretion (TNF-α, IFN-γ)</td><td>–</td><td>+</td><td>++</td></tr><tr><td colspan="4">Signaling pathways</td></tr><tr>... |
4f32026ce8c83dab76977e207c1724e23b8c1663d4f2469139d4b7ba4bc8f61b.png | complex | <table><tr><td>Amendment</td><td>Concentration</td><td>m<sub>N</sub><sup>a</sup></td><td>Effectiveness</td></tr><tr><td rowspan="3">Aldrich Humic Acid</td><td>1 mg C L<sup>-1</sup></td><td>0.7(0)</td><td>LS</td></tr><tr><td>5 mg C L<sup>-1</sup></td><td>0.3(6)</td><td>LS</td></tr><tr><td>10 mg C L<sup>-1</sup></td><td>... | <table><tr><td>Amendment</td><td>Concentration</td><td>mNa</td></tr><tr><td rowspan="3">Aldrich Humic Acid</td><td>1 mg C L-1</td><td>0.7(0)</td></tr><tr><td>5 mg C L-1</td><td>0.3(6)</td></tr><tr><td>10 mg C L-1</td><td>0.3(7)</td></tr><tr><td rowspan="3">IHSS Humic Acid</td><td>1 mg C L-1</td><td>0.8(4)</td></tr><tr>... | <table><tr><td>Effectiveness</td></tr><tr><td>LS</td></tr><tr><td>LS</td></tr><tr><td>LS</td></tr><tr><td>LS</td></tr><tr><td>LS</td></tr><tr><td>LS</td></tr><tr><td>LS</td></tr><tr><td>LS</td></tr><tr><td>LS</td></tr><tr><td>NR</td></tr><tr><td>LS</td></tr></table> |
95598a4906a9f2c28b112b5dc5e76dbaacc3482b41f077e1ab5c1bb3baa54f89.png | complex | <table><tr><td>Variable</td><td>HBV</td><td>%</td><td><i>Odds ratio</i></td><td><i>p</i></td></tr><tr><td>Year</td><td>Positive/Total</td><td> </td><td>(95% CI)</td><td> </td></tr><tr><td>2001*</td><td>52/552</td><td>9.42</td><td rowspan="2">3.31 (2.40-4.57)</td><td rowspan="2">< 0.01</td></tr><tr><td>2010</td><td>2... | <table><tr><td>Variable</td><td>HBV</td><td>%</td><td>Odds ratio</td></tr><tr><td>Year</td><td>Positive/Total</td><td></td><td>(95% CI)</td></tr><tr><td>2001*</td><td>52/552</td><td>9.42</td><td rowspan="2">3.31 (2.40-4.57)</td></tr><tr><td>2010</td><td>269/8,840</td><td>3.04</td></tr></table> | <table><tr><td>p</td></tr><tr><td></td></tr><tr><td rowspan="2">< 0.01</td></tr><tr></tr></table> |
dc5f675f4652ba6ae5481e47b21a80c122a7fdb6148f8729afb7260178fba33c.png | simple | <table><tr><td>Chromosome</td><td>AntiSMASH</td><td>SMURF</td><td>Unique NP</td></tr><tr><td>I</td><td>1</td><td>1</td><td>1</td></tr><tr><td>II</td><td>3</td><td>1</td><td>4</td></tr><tr><td>III</td><td>4</td><td>4</td><td>5</td></tr><tr><td>IV</td><td>3</td><td>1</td><td>4</td></tr><tr><td>V</td><td>6</td><td>6</td><... | <table><tr><td>Chromosome</td><td>AntiSMASH</td><td>SMURF</td><td>Unique NP</td></tr><tr><td>I</td><td>1</td><td>1</td><td>1</td></tr><tr><td>II</td><td>3</td><td>1</td><td>4</td></tr><tr><td>III</td><td>4</td><td>4</td><td>5</td></tr><tr><td>IV</td><td>3</td><td>1</td><td>4</td></tr></table> | <table><tr><td>V</td><td>6</td><td>6</td><td>7</td></tr><tr><td>VI</td><td>8</td><td>6</td><td>8</td></tr><tr><td>VII</td><td>7</td><td>6</td><td>7</td></tr><tr><td>Total</td><td>32</td><td>25</td><td>36</td></tr></table> |
8732a491314a5b2c62f2b500a195bcbc0d6fe51f048273e065e58829c489ca92.png | complex | <table><tr><td></td><td>n (%)</td></tr><tr><td colspan="2">Primary clinical composite diagnoses</td></tr><tr><td> Anterior cruciate ligament injury</td><td>8 (5)</td></tr><tr><td> Meniscal injury</td><td>36 (20)</td></tr><tr><td> Patellofemoral Pain Syndrome</td><td>45 (25)</td></tr><tr><td> Osteoarthritis</td><td>79 (... | <table><tr><td></td></tr><tr><td>Primary clinical composite diagnoses</td></tr><tr><td>Anterior cruciate ligament injury</td></tr><tr><td>Meniscal injury</td></tr><tr><td>Patellofemoral Pain Syndrome</td></tr><tr><td>Osteoarthritis</td></tr><tr><td>Other knee diagnoses</td></tr><tr><td>Imaging findings and diagnoses</t... | <table><tr><td>n (%)</td></tr><tr><td>Primary clinical composite diagnoses</td></tr><tr><td>8 (5)</td></tr><tr><td>36 (20)</td></tr><tr><td>45 (25)</td></tr><tr><td>79 (44)</td></tr><tr><td>11 (6)</td></tr><tr><td>Imaging findings and diagnoses</td></tr><tr><td>96 (56)</td></tr><tr><td>14 (15)</td></tr><tr><td>36 (38)<... |
e5c92916e322f51d50e3ee07a141fd653d793e92a556cf59be026ed562606f01.png | simple | <table><tr><td></td><td>0d</td><td>3d</td><td>6d</td><td>9d</td><td>12d</td><td>15d</td><td>18d</td><td>21d</td><td>24d</td><td>27d</td><td>30d</td><td>33d</td><td>36d</td><td>39d</td><td>42d</td><td>45d</td><td>48d</td><td>51d</td><td>54d</td><td>57d</td><td>60d</td><td>63d</td><td>≥ 66d</td></tr><tr><td># of CT... | <table><tr><td></td><td>0d</td><td>3d</td><td>6d</td><td>9d</td><td>12d</td><td>15d</td><td>18d</td><td>21d</td><td>24d</td><td>27d</td><td>30d</td><td>33d</td><td>36d</td><td>39d</td><td>42d</td><td>45d</td><td>48d</td><td>51d</td><td>54d</td><td>57d</td><td>60d</td><td>63d</td><td>≥ 66d</td></tr><tr><td># of CTGR-SPs... | <table><tr><td></td><td>0d</td><td>3d</td><td>6d</td><td>9d</td><td>12d</td><td>15d</td><td>18d</td><td>21d</td><td>24d</td><td>27d</td><td>30d</td><td>33d</td><td>36d</td><td>39d</td><td>42d</td><td>45d</td><td>48d</td><td>51d</td><td>54d</td><td>57d</td><td>60d</td><td>63d</td><td>≥ 66d</td></tr><tr><td># of genes in... |
6924d401fd0b856d3b289ec313931fbf18aba667109ab648748c653444575e97.png | complex | <table><tr><td rowspan="3">Part of Intestine</td><td colspan="2">Control group</td><td colspan="2">Pomegranate treated group</td><td colspan="2">Sodium.butyrate treated group</td></tr><tr><td>Non-everted (μg)</td><td>Everted (μg)</td><td>Non-everted (μg)</td><td>Everted (μg)</td><td>Non-everted (	... | <table><tr><td rowspan="3">Part of Intestine</td><td colspan="2">Control group</td><td colspan="2">Pomegranate treated group</td><td>Sodium.butyrate treated group</td></tr><tr><td>Non-everted (μg)</td><td>Everted (μg)</td><td>Non-everted (μg)</td><td>Everted (μg)</td><td>Non-everted (μg)</td></tr><tr><td colspan="5"></... | <table><tr><td>Sodium.butyrate treated group</td></tr><tr><td>Everted (μg)</td></tr><tr><td></td></tr><tr><td>15.5±0.3</td></tr><tr><td>14.3±0.3</td></tr><tr><td>16.8±0.8†</td></tr><tr><td>14.5±0.3†</td></tr></table> |
a309c6393b5461670b9ec048aa56a98d53815eb0322080d5df2287b6280252e7.png | simple | <table><tr><td></td><td>Discharged</td><td>Expired</td></tr><tr><td></td><td>32</td><td>18</td></tr><tr><td>Tracheostomy</td><td>26.5</td><td>23.5</td></tr><tr><td></td><td>1.141</td><td>1.30</td></tr><tr><td></td><td>21</td><td>29</td></tr><tr><td>Non Tracheostomy</td><td>26.5</td><td>23.5</td></tr><tr><td></td><td>1.... | <table><tr><td></td></tr><tr><td></td></tr><tr><td>Tracheostomy</td></tr><tr><td></td></tr><tr><td></td></tr><tr><td>Non Tracheostomy</td></tr><tr><td></td></tr></table> | <table><tr><td>Discharged</td><td>Expired</td></tr><tr><td>32</td><td>18</td></tr><tr><td>26.5</td><td>23.5</td></tr><tr><td>1.141</td><td>1.30</td></tr><tr><td>21</td><td>29</td></tr><tr><td>26.5</td><td>23.5</td></tr><tr><td>1.141</td><td>1.30</td></tr></table> |
6f6adfe73321e5611bfa59a161cb2012a61f77c5576d7196431723a739c49a34.png | simple | <table><tr><td> </td><td>BRCA1</td><td>BRCA2</td><td>Non-BRCA1/2</td></tr><tr><td>All males in kConFab registry</td><td>429</td><td>339</td><td>19137</td></tr><tr><td>Breast Cancers</td><td>5 (1.2%)</td><td>35 (10.3%)</td><td>78 (0.4%)</td></tr><tr><td>Pathology Available</td><td>3</td><td>25</td><td>32</td></tr></tabl... | <table><tr><td></td><td>BRCA1</td><td>BRCA2</td><td>Non-BRCA1/2</td></tr><tr><td>All males in kConFab registry</td><td>429</td><td>339</td><td>19137</td></tr><tr><td>Breast Cancers</td><td>5 (1.2%)</td><td>35 (10.3%)</td><td>78 (0.4%)</td></tr></table> | <table><tr><td>Pathology Available</td><td>3</td><td>25</td><td>32</td></tr></table> |
2464281b7e42f8d8c51dcb219b3896d4f3f43b65f3da349a9e6c734c7d9a1f24.png | simple | <table><tr><td>Patients with HPA</td><td>Gender</td><td>Age</td><td>Mechanism of trauma</td><td>Liver injury grade*</td><td>Symptoms of HPA</td><td>Blood transfusion</td></tr><tr><td>1</td><td>Female</td><td>25</td><td>Blunt</td><td>2</td><td>No</td><td>No</td></tr><tr><td>2</td><td>Male</td><td>20</td><td>Blunt</td><t... | <table><tr><td>Patients with HPA</td><td>Gender</td><td>Age</td><td>Mechanism of trauma</td><td>Liver injury grade*</td><td>Symptoms of HPA</td></tr><tr><td>1</td><td>Female</td><td>25</td><td>Blunt</td><td>2</td><td>No</td></tr><tr><td>2</td><td>Male</td><td>20</td><td>Blunt</td><td>2</td><td>Yes</td></tr><tr><td>3</t... | <table><tr><td>Blood transfusion</td></tr><tr><td>No</td></tr><tr><td>Yes</td></tr><tr><td>No</td></tr><tr><td>No</td></tr><tr><td>Yes</td></tr><tr><td>No</td></tr><tr><td>No</td></tr></table> |
0cd07bfd47076ea2d32ce6e52a11eba8e6155b4c2743aa9aad0f840ba470b286.png | simple | <table><tr><td>Age groups of Males/females </td><td>Quantity of interviewees</td></tr><tr><td>50-60 (10 males)</td><td>10</td></tr><tr><td>63-69 (20 males/5 females)</td><td>25</td></tr><tr><td>70-75 (10 male hakims/7 females)</td><td>17</td></tr><tr><td>75-80 (8 female)</td><td>8</td></tr></table> | <table><tr><td>Age groups of Males/females</td></tr><tr><td>50-60 (10 males)</td></tr><tr><td>63-69 (20 males/5 females)</td></tr><tr><td>70-75 (10 male hakims/7 females)</td></tr><tr><td>75-80 (8 female)</td></tr></table> | <table><tr><td>Quantity of interviewees</td></tr><tr><td>10</td></tr><tr><td>25</td></tr><tr><td>17</td></tr><tr><td>8</td></tr></table> |
da1454e4a51c2473b02bc0994f853e83fda54124b2f2a6b0fa59377c1236bfc7.png | simple | <table><tr><td>Gene <sup>a</sup></td><td>Region</td><td>Size</td><td>Inc <sup>b</sup></td><td>AT%</td><td>AT-Skew <sup>c</sup></td><td>GC-Skew</td><td>Start Codon</td><td>Stop Codon</td><td>Anticodon</td></tr><tr><td><i>cox1</i></td><td>1–1539</td><td>1539</td><td>1</td><td>64.39</td><td>−0.322</td><td>0.26... | <table><tr><td>Gene a</td><td>Region</td><td>Size</td><td>Inc b</td><td>AT%</td><td>AT-Skew c</td><td>GC-Skew</td><td>Start Codon</td><td>Stop Codon</td><td>Anticodon</td></tr><tr><td>cox1</td><td>1–1539</td><td>1539</td><td>1</td><td>64.39</td><td>−0.322</td><td>0.263</td><td>ATG</td><td>TAA</td><td>-</td></tr><tr><td... | <table><tr><td>Gene a</td><td>Region</td><td>Size</td><td>Inc b</td><td>AT%</td><td>AT-Skew c</td><td>GC-Skew</td><td>Start Codon</td><td>Stop Codon</td><td>Anticodon</td></tr><tr><td>nad2</td><td>14029–15003</td><td>975</td><td>0</td><td>68.72</td><td>−0.287</td><td>0.279</td><td>ATA</td><td>TAA</td><td>-</td></tr><tr... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.